In	O
vivo	O
control	O
of	O
NF-kappa	B-protein
B	I-protein
activation	O
by	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
.	O

The	O
transcription	B-protein
factor	I-protein
NF-kappa	B-protein
B	I-protein
is	O
stored	O
in	O
the	O
cytoplasm	O
in	O
complexes	O
with	O
the	O
inhibitor	B-protein
protein	I-protein
I	I-protein
kappa	I-protein
B	I-protein
alpha	I-protein
.	O

It	O
has	O
been	O
shown	O
in	O
vitro	O
that	O
dissociation	O
of	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
from	O
these	O
complexes	O
results	O
in	O
active	B-protein
NF-kappa	I-protein
B	I-protein
.	O

In	O
this	O
report	O
we	O
show	O
that	O
lipopolysaccharide	O
(	O
LPS	O
)	O
-induced	O
activation	O
of	O
B	B-cell_type
or	I-cell_type
pre-B	I-cell_type
cells	I-cell_type
results	O
in	O
loss	O
of	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
from	O
NF-kappa	B-protein
B	I-protein
complexes	I-protein
in	O
vivo	O
.	O

Many	O
liberated	O
NF-kappa	B-protein
B	I-protein
dimers	I-protein
reached	O
the	O
nucleus	O
,	O
where	O
increased	O
c-rel	B-protein
,	O
p65	O
and	O
p50	O
were	O
detected	O
by	O
immunoblotting	O
and	O
by	O
DNA	O
binding	O
assays	O
.	O

Some	O
liberated	B-protein
dimers	I-protein
were	O
retained	O
in	O
the	O
cytoplasm	O
,	O
however	O
,	O
through	O
binding	O
to	O
newly	O
synthesized	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
,	O
a	O
finding	O
which	O
strongly	O
suggests	O
(	O
i	O
)	O
that	O
the	O
LPS-induced	O
signal	O
causes	O
dissociation	O
of	O
complexes	O
rather	O
than	O
preventing	O
their	O
association	O
and	O
(	O
ii	O
)	O
that	O
dissociation	O
results	O
from	O
modification	O
of	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
and	O
not	O
of	O
c-rel	B-protein
or	O
p65	B-protein
.	O

No	O
effect	O
of	O
LPS	O
treatment	O
was	O
detected	O
on	O
p105	B-protein
or	O
p100	B-protein
,	O
which	O
also	O
retain	O
rel	B-protein
family	I-protein
members	I-protein
in	O
the	O
cytoplasm	O
.	O

Quite	O
unexpectedly	O
,	O
we	O
also	O
found	O
that	O
in	O
unstimulated	B-cell_type
cells	I-cell_type
there	O
is	O
a	O
constant	O
ongoing	O
process	O
of	O
degradation	O
and	O
replacement	O
of	O
complexed	B-protein
I	I-protein
kappa	I-protein
B	I-protein
alpha	I-protein
.	O

We	O
propose	O
that	O
this	O
turnover	O
results	O
in	O
the	O
low	O
level	O
of	O
active	B-protein
NF-kappa	I-protein
B	I-protein
presumably	O
necessary	O
even	O
in	O
the	O
unstimulated	O
cell	O
,	O
and	O
that	O
the	O
high	O
rate	O
of	O
synthesis	O
of	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
provides	O
the	O
ability	O
to	O
turn	O
off	O
NF-kappa	B-protein
B	I-protein
activity	O
rapidly	O
as	O
soon	O
as	O
the	O
activating	O
signal	O
ceases	O
.	O

The	NULL
EMBO	NULL
Journal	NULL
vol	NULL
.	NULL

12	NULL
no.12	NULL
pp.4685-4695	NULL
,	NULL
1993	NULL
In	NULL
vivo	NULL
control	NULL
of	NULL
NF-xB	NULL
activation	NULL
by	NULL
IxBa	NULL
Nancy	NULL
R.Rice	NULL
and	NULL
Mary	NULL
K.Ernst	NULL
Laboratory	NULL
of	NULL
Molecular	NULL
Virology	NULL
and	NULL
Carcinogenesis	NULL
,	NULL
ABL-Basic	NULL
Research	NULL
Program	NULL
,	NULL
NCI-Frederick	NULL
Cancer	NULL
Research	NULL
and	NULL
Development	NULL
Center	NULL
,	NULL
Frederick	NULL
,	NULL
MD	NULL
21702-1201	NULL
,	NULL
USA	NULL
Communicated	NULL
by	NULL
F.Blasi	NULL
The	NULL
transcription	NULL
factor	NULL
NF-xB	NULL
is	NULL
stored	NULL
in	NULL
the	NULL
cytoplasm	NULL
in	NULL
complexes	NULL
with	NULL
the	NULL
inhibitor	NULL
protein	NULL
IxBa	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
in	NULL
vitro	NULL
that	NULL
dissociation	NULL
of	NULL
IxBa	NULL
from	NULL
these	NULL
complexes	NULL
results	NULL
in	NULL
active	NULL
NF-xB	NULL
.	NULL

In	NULL
this	NULL
report	NULL
we	NULL
show	NULL
that	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
-induced	NULL
activation	NULL
of	NULL
B	NULL
or	NULL
pre-B	NULL
cells	NULL
results	NULL
in	NULL
loss	NULL
of	NULL
IxBa	NULL
from	NULL
NF-xB	NULL
complexes	NULL
in	NULL
vivo	NULL
.	NULL

Many	NULL
liberated	NULL
NF-xB	NULL
dimers	NULL
reached	NULL
the	NULL
nucleus	NULL
,	NULL
where	NULL
increased	NULL
c-re/	NULL
,	NULL
p65	NULL
and	NULL
p50	NULL
were	NULL
detected	NULL
by	NULL
immunoblotting	NULL
and	NULL
by	NULL
DNA	NULL
binding	NULL
assays	NULL
.	NULL

Some	NULL
liberated	NULL
dimers	NULL
were	NULL
retained	NULL
in	NULL
the	NULL
cytoplasm	NULL
,	NULL
however	NULL
,	NULL
through	NULL
binding	NULL
to	NULL
newly	NULL
synthesized	NULL
IxBa	NULL
,	NULL
a	NULL
finding	NULL
which	NULL
strongly	NULL
suggests	NULL
(	NULL
i	NULL
)	NULL
that	NULL
the	NULL
LPS-induced	NULL
signal	NULL
causes	NULL
dissociation	NULL
of	NULL
complexes	NULL
rather	NULL
than	NULL
preventing	NULL
their	NULL
association	NULL
and	NULL
(	NULL
ii	NULL
)	NULL
that	NULL
dissociation	NULL
results	NULL
from	NULL
modification	NULL
of	NULL
IxBa	NULL
and	NULL
not	NULL
of	NULL
c-rel	NULL
or	NULL
p65	NULL
.	NULL

No	NULL
effect	NULL
of	NULL
LPS	NULL
treatment	NULL
was	NULL
detected	NULL
on	NULL
p105	NULL
or	NULL
p100	NULL
,	NULL
which	NULL
also	NULL
retain	NULL
re	NULL
?	NULL

family	NULL
members	NULL
in	NULL
the	NULL
cytoplasm	NULL
.	NULL

Quite	NULL
unexpectedly	NULL
,	NULL
we	NULL
also	NULL
found	NULL
that	NULL
in	NULL
unstimulated	NULL
cells	NULL
there	NULL
is	NULL
a	NULL
constant	NULL
ongoing	NULL
process	NULL
of	NULL
degradation	NULL
and	NULL
replacement	NULL
of	NULL
complexed	NULL
IxBa	NULL
.	NULL

We	NULL
propose	NULL
that	NULL
this	NULL
turnover	NULL
results	NULL
in	NULL
the	NULL
low	NULL
level	NULL
of	NULL
active	NULL
NF-xB	NULL
presumably	NULL
necessary	NULL
even	NULL
in	NULL
the	NULL
unstimulated	NULL
cell	NULL
,	NULL
and	NULL
that	NULL
the	NULL
high	NULL
rate	NULL
of	NULL
synthesis	NULL
of	NULL
IxBa	NULL
provides	NULL
the	NULL
ability	NULL
to	NULL
turn	NULL
off	NULL
NF-xB	NULL
activity	NULL
rapidly	NULL
as	NULL
soon	NULL
as	NULL
the	NULL
activating	NULL
signal	NULL
ceases	NULL
.	NULL

Key	NULL
words	NULL
:	NULL
c-rel/lxBa/NF-xB/transcription	NULL
factor/regulatory	NULL
complexes	NULL
Introduction	NULL
Nuclear	NULL
factor-xB	NULL
(	NULL
NF-xB	NULL
)	NULL
(	NULL
Sen	NULL
and	NULL
Baltimore	NULL
,	NULL
19862	NULL
)	NULL
is	NULL
a	NULL
transcription	NULL
factor	NULL
that	NULL
plays	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
numerous	NULL
genes	NULL
,	NULL
including	NULL
many	NULL
of	NULL
those	NULL
involved	NULL
in	NULL
immune	NULL
or	NULL
inflammatory	NULL
responses	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Grilli	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

As	NULL
originally	NULL
described	NULL
,	NULL
NF-xB	NULL
was	NULL
a	NULL
heterodimer	NULL
composed	NULL
of	NULL
a	NULL
p50	NULL
and	NULL
p65	NULL
subunit	NULL
(	NULL
Baeuerle	NULL
and	NULL
Baltimore	NULL
,	NULL
1989	NULL
;	NULL
Ghosh	NULL
and	NULL
Baltimore	NULL
,	NULL
1990	NULL
)	NULL
,	NULL
but	NULL
it	NULL
is	NULL
now	NULL
known	NULL
that	NULL
there	NULL
are	NULL
five	NULL
different	NULL
proteins	NULL
that	NULL
can	NULL
participate	NULL
in	NULL
dimer	NULL
formation	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
p50	NULL
and	NULL
p65	NULL
,	NULL
these	NULL
are	NULL
p52	NULL
,	NULL
c-rel	NULL
and	NULL
rel	NULL
B	NULL
(	NULL
also	NULL
called	NULL
I-rel	NULL
)	NULL
.	NULL

All	NULL
are	NULL
related	NULL
over	NULL
a	NULL
stretch	NULL
of	NULL
~300	NULL
amino	NULL
acids	NULL
to	NULL
the	NULL
c-rel	NULL
oncogene	NULL
and	NULL
to	NULL
the	NULL
Drosophila	NULL
morphogen	NULL
dorsal	NULL
(	NULL
Ballard	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Ghosh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Kieran	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Neri	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Nolan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Ruben	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
,	NULL
1992a	NULL
;	NULL
Schmid	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Ryseck	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

DNA-binding	NULL
dimers	NULL
can	NULL
be	NULL
homodimers	NULL
(	NULL
except	NULL
for	NULL
rel	NULL
B	NULL
)	NULL
or	NULL
many	NULL
(	NULL
or	NULL
perhaps	NULL
all	NULL
)	NULL
of	NULL
the	NULL
possible	NULL
heterodimers	NULL
[	NULL
see	NULL
above	NULL
references	NULL
plus	NULL
Inoue	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
,	NULL
Urban	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
,	NULL
Hansen	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
and	NULL
Perkins	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
]	NULL
.	NULL

Transcriptional	NULL
activation	NULL
is	NULL
due	NULL
chiefly	NULL
to	NULL
p65	NULL
,	NULL
c-rel	NULL
and	NULL
rel	NULL
B	NULL
(	NULL
Bull	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Inoue	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Schmitz	NULL
and	NULL
Bacuerle	NULL
,	NULL
1991	NULL
;	NULL
Ballard	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Ruben	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992b	NULL
;	NULL
Ryseck	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
although	NULL
under	NULL
certain	NULL
conditions	NULL
p50	NULL
homodimers	NULL
can	NULL
also	NULL
transactivate	NULL
(	NULL
Fujita	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

NF-xB	NULL
activity	NULL
is	NULL
constitutive	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
in	NULL
some	NULL
monocyte	NULL
cell	NULL
lines	NULL
,	NULL
but	NULL
in	NULL
most	NULL
other	NULL
cells	NULL
it	NULL
is	NULL
very	NULL
low	NULL
or	NULL
undetectable	NULL
.	NULL

However	NULL
,	NULL
NF-xB	NULL
activity	NULL
can	NULL
be	NULL
rapidly	NULL
induced	NULL
in	NULL
most	NULL
cells	NULL
by	NULL
treatment	NULL
with	NULL
any	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
agents	NULL
,	NULL
e.g	NULL
.	NULL

phorbol	NULL
esters	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
or	NULL
hydrogen	NULL
peroxide	NULL
(	NULL
for	NULL
review	NULL
see	NULL
Grilli	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
in	NULL
most	NULL
cases	NULL
this	NULL
induction	NULL
does	NULL
not	NULL
require	NULL
protein	NULL
synthesis	NULL
(	NULL
Sen	NULL
and	NULL
Baltimore	NULL
,	NULL
1986b	NULL
;	NULL
Hohmann	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
led	NULL
to	NULL
the	NULL
discovery	NULL
that	NULL
NF-xB	NULL
is	NULL
stored	NULL
in	NULL
inactive	NULL
form	NULL
in	NULL
the	NULL
cytoplasm	NULL
(	NULL
Baeuerle	NULL
and	NULL
Baltimore	NULL
,	NULL
1988	NULL
)	NULL
.	NULL

Storage	NULL
of	NULL
c-rel-	NULL
and	NULL
p65-containing	NULL
dimers	NULL
is	NULL
accomplished	NULL
through	NULL
binding	NULL
to	NULL
one	NULL
of	NULL
several	NULL
inhibitor	NULL
proteins	NULL
.	NULL

One	NULL
of	NULL
the	NULL
inhibitors	NULL
is	NULL
the	NULL
high	NULL
molecular	NULL
weight	NULL
precursor	NULL
to	NULL
p50	NULL
(	NULL
Rice	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Both	NULL
p50	NULL
and	NULL
p52	NULL
are	NULL
synthesized	NULL
as	NULL
inactive	NULL
cytoplasmic	NULL
precursors	NULL
(	NULL
p105	NULL
and	NULL
p100	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
of	NULL
which	NULL
the	NULL
N-terminal	NULL
halves	NULL
constitute	NULL
the	NULL
active	NULL
DNA-binding	NULL
form	NULL
(	NULL
Bours	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
,	NULL
1992	NULL
;	NULL
Ghosh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Kieran	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Meyer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Neri	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Schmid	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

A	NULL
significant	NULL
fraction	NULL
of	NULL
p105	NULL
is	NULL
bound	NULL
to	NULL
c-re/	NULL
or	NULL
p65	NULL
,	NULL
and	NULL
these	NULL
p105/c-rel	NULL
and	NULL
p105/p65	NULL
dimers	NULL
are	NULL
strictly	NULL
cytoplasmic	NULL
and	NULL
unable	NULL
to	NULL
bind	NULL
DNA	NULL
.	NULL

Processing	NULL
of	NULL
p105	NULL
to	NULL
p50	NULL
occurs	NULL
slowly	NULL
(	NULL
Fan	NULL
and	NULL
Maniatis	NULL
,	NULL
1991	NULL
)	NULL
,	NULL
but	NULL
gradually	NULL
leads	NULL
to	NULL
the	NULL
appearance	NULL
of	NULL
p50/p65	NULL
and	NULL
p50/rel	NULL
dimers	NULL
(	NULL
Rice	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Whether	NULL
the	NULL
rate	NULL
of	NULL
processing	NULL
is	NULL
influenced	NULL
by	NULL
stimulation	NULL
of	NULL
the	NULL
cell	NULL
is	NULL
not	NULL
yet	NULL
clear	NULL
.	NULL

In	NULL
a	NULL
similar	NULL
manner	NULL
,	NULL
p100	NULL
,	NULL
the	NULL
precursor	NULL
of	NULL
p52	NULL
,	NULL
also	NULL
retains	NULL
c-rel	NULL
and	NULL
p65	NULL
in	NULL
the	NULL
cytoplasm	NULL
(	NULL
Mercurio	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

The	NULL
most	NULL
extensively	NULL
studied	NULL
inhibitor	NULL
of	NULL
the	NULL
rel	NULL
family	NULL
proteins	NULL
is	NULL
IxBax	NULL
,	NULL
the	NULL
product	NULL
of	NULL
the	NULL
MAD-3	NULL
gene	NULL
(	NULL
Haskill	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
and	NULL
the	NULL
human	NULL
homolog	NULL
of	NULL
chicken	NULL
pp4O	NULL
(	NULL
Davis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
and	NULL
rat	NULL
RL/IF-1	NULL
(	NULL
Tewari	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

In	NULL
vitro	NULL
,	NULL
it	NULL
binds	NULL
efficiently	NULL
to	NULL
c-re/	NULL
,	NULL
p65	NULL
and	NULL
rel	NULL
B	NULL
and	NULL
prevents	NULL
DNA	NULL
binding	NULL
by	NULL
their	NULL
homo-	NULL
or	NULL
heterodimers	NULL
(	NULL
Zabel	NULL
and	NULL
Baeuerle	NULL
,	NULL
1990	NULL
;	NULL
Kerr	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Wulezyn	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

It	NULL
also	NULL
binds	NULL
to	NULL
p50	NULL
homodimers	NULL
but	NULL
does	NULL
not	NULL
prevent	NULL
their	NULL
binding	NULL
to	NULL
DNA	NULL
(	NULL
Beg	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Cytoplasmic	NULL
IxBa	NULL
complexes	NULL
are	NULL
thought	NULL
to	NULL
be	NULL
major	NULL
targets	NULL
in	NULL
signal	NULL
transduction	NULL
pathways	NULL
.	NULL

It	NULL
is	NULL
known	NULL
that	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
in	NULL
vitro	NULL
prevents	NULL
its	NULL
binding	NULL
to	NULL
rel	NULL
and	NULL
to	NULL
p50/p65	NULL
(	NULL
Shirakawa	NULL
and	NULL
Mizel	NULL
,	NULL
1989	NULL
;	NULL
Ghosh	NULL
and	NULL
Baltimore	NULL
,	NULL
1990	NULL
;	NULL
Kerr	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
and	NULL
it	NULL
is	NULL
presumed	NULL
that	NULL
phosphorylation	NULL
regulates	NULL
association	NULL
in	NULL
vivo	NULL
as	NULL
well	NULL
.	NULL

Whatever	NULL
the	NULL
precise	NULL
mechanism	NULL
,	NULL
the	NULL
working	NULL
hypothesis	NULL
is	NULL
that	NULL
stimulation	NULL
of	NULL
the	NULL
cell	NULL
results	NULL
in	NULL
loss	NULL
of	NULL
IxBa	NULL
from	NULL
cytoplasmic	NULL
complexes	NULL
,	NULL
transport	NULL
of	NULL
rel	NULL
family	NULL
proteins	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
followed	NULL
by	NULL
DNA	NULL
binding	NULL
and	NULL
gene	NULL
activation	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
scenario	NULL
,	NULL
stimulation	NULL
of	NULL
cells	NULL
with	NULL
agents	NULL
such	NULL
as	NULL
TNFa	NULL
results	NULL
in	NULL
the	NULL
rapid	NULL
disappearance	NULL
4685	NULL
N.R.Rice	NULL
and	NULL
M.K.Ernst	NULL
of	NULL
IxBa	NULL
,	NULL
as	NULL
monitored	NULL
by	NULL
immunoblotting	NULL
(	NULL
Brown	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Sun	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

In	NULL
this	NULL
paper	NULL
we	NULL
examine	NULL
IxBa-containing	NULL
complexes	NULL
directly	NULL
,	NULL
by	NULL
immunoprecipitation	NULL
.	NULL

We	NULL
show	NULL
that	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
stimulation	NULL
of	NULL
murine	NULL
B	NULL
and	NULL
pre-B	NULL
cells	NULL
results	NULL
in	NULL
loss	NULL
of	NULL
IxBa	NULL
from	NULL
all	NULL
pre-existing	NULL
c-re/-and	NULL
p65-containing	NULL
dimers	NULL
,	NULL
in	NULL
accordance	NULL
with	NULL
the	NULL
working	NULL
model	NULL
.	NULL

Some	NULL
but	NULL
not	NULL
all	NULL
of	NULL
the	NULL
liberated	NULL
c-re/	NULL
and	NULL
p65	NULL
translocates	NULL
to	NULL
the	NULL
nucleus	NULL
and	NULL
exhibits	NULL
DNA-binding	NULL
activity	NULL
.	NULL

The	NULL
remaining	NULL
c-rel	NULL
and	NULL
p65	NULL
are	NULL
captured	NULL
by	NULL
newly	NULL
synthesized	NULL
IxBa	NULL
and	NULL
retained	NULL
in	NULL
the	NULL
cytoplasm	NULL
,	NULL
a	NULL
result	NULL
which	NULL
strongly	NULL
suggests	NULL
that	NULL
complexes	NULL
dissociate	NULL
because	NULL
of	NULL
modification	NULL
of	NULL
IxBa	NULL
,	NULL
not	NULL
of	NULL
c-rel	NULL
or	NULL
p65	NULL
.	NULL

We	NULL
also	NULL
examine	NULL
IxBa	NULL
complexes	NULL
in	NULL
unstimulated	NULL
cells	NULL
and	NULL
find	NULL
a	NULL
quite	NULL
unexpected	NULL
dynamism	NULL
.	NULL

While	NULL
c-re/	NULL
and	NULL
p65	NULL
are	NULL
stable	NULL
proteins	NULL
,	NULL
complexed	NULL
IxBa	NULL
turns	NULL
over	NULL
with	NULL
a	NULL
half-life	NULL
of	NULL
30-60	NULL
min	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
cell	NULL
lines	NULL
.	NULL

We	NULL
propose	NULL
that	NULL
this	NULL
turnover	NULL
results	NULL
in	NULL
the	NULL
low	NULL
level	NULL
of	NULL
active	NULL
NF-xB	NULL
that	NULL
is	NULL
presumably	NULL
necessary	NULL
even	NULL
in	NULL
the	NULL
unstimulated	NULL
cell	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
suggest	NULL
that	NULL
the	NULL
high	NULL
rate	NULL
of	NULL
synthesis	NULL
of	NULL
IxBa	NULL
relative	NULL
to	NULL
that	NULL
of	NULL
rel	NULL
family	NULL
members	NULL
provides	NULL
the	NULL
ability	NULL
to	NULL
turn	NULL
off	NULL
NF-xB	NULL
activity	NULL
rapidly	NULL
as	NULL
soon	NULL
as	NULL
the	NULL
activating	NULL
signal	NULL
ceases	NULL
.	NULL

Results	NULL
Activation	NULL
of	NULL
cells	NULL
results	NULL
in	NULL
dissociation	NULL
of	NULL
IxBa	NULL
To	NULL
test	NULL
the	NULL
effect	NULL
of	NULL
cellular	NULL
stimulation	NULL
on	NULL
IxBa	NULL
,	NULL
we	NULL
determined	NULL
the	NULL
response	NULL
of	NULL
the	NULL
murine	NULL
B	NULL
cell	NULL
line	NULL
WEHI	NULL
231	NULL
and	NULL
of	NULL
the	NULL
murine	NULL
pre-B	NULL
cell	NULL
line	NULL
70Z/3	NULL
to	NULL
bacterial	NULL
LPS	NULL
,	NULL
an	NULL
effective	NULL
activator	NULL
of	NULL
these	NULL
cells	NULL
(	NULL
Sen	NULL
and	NULL
Baltimore	NULL
,	NULL
1986b	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
grown	NULL
in	NULL
*°S-containing	NULL
medium	NULL
for	NULL
1	NULL
h	NULL
,	NULL
and	NULL
then	NULL
in	NULL
non-radioactive	NULL
medium	NULL
with	NULL
or	NULL
without	NULL
LPS	NULL
.	NULL

We	NULL
asked	NULL
whether	NULL
[	NULL
*°S	NULL
]	NULL
IxBa	NULL
would	NULL
be	NULL
lost	NULL
from	NULL
rel	NULL
family	NULL
complexes	NULL
during	NULL
incubation	NULL
of	NULL
the	NULL
cells	NULL
in	NULL
LPS	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
702/3	NULL
cells	NULL
,	NULL
cytoplasmic	NULL
extract	NULL
was	NULL
immunoprecipitated	NULL
with	NULL
both	NULL
anti-c-re/	NULL
and	NULL
anti-p65	NULL
(	NULL
see	NULL
Figure	NULL
1	NULL
for	NULL
description	NULL
of	NULL
antisera	NULL
)	NULL
.	NULL

The	NULL
washed	NULL
precipitate	NULL
was	NULL
released	NULL
from	NULL
antibody	NULL
by	NULL
incubation	NULL
in	NULL
excess	NULL
competing	NULL
peptides	NULL
and	NULL
the	NULL
eluted	NULL
(	NULL
c-re/-	NULL
and	NULL
p65-containing	NULL
)	NULL
material	NULL
was	NULL
reprecipitated	NULL
as	NULL
indicated	NULL
in	NULL
Figure	NULL
2A	NULL
.	NULL

In	NULL
cells	NULL
chased	NULL
for	NULL
90	NULL
min	NULL
without	NULL
LPS	NULL
,	NULL
both	NULL
anti-c-re/	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
and	NULL
anti-p65	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
precipitated	NULL
[	NULL
*°S	NULL
]	NULL
IxBa	NULL
,	NULL
as	NULL
expected	NULL
,	NULL
and	NULL
anti-IxBa	NULL
precipitated	NULL
*°S-labeled	NULL
IxBa	NULL
,	NULL
c-re/	NULL
and	NULL
p65	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

In	NULL
LPS-treated	NULL
cells	NULL
,	NULL
however	NULL
,	NULL
neither	NULL
anti-c-re/	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
nor	NULL
anti-p65	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
precipitated	NULL
[	NULL
*°S	NULL
)	NULL
]	NULL
IxBa	NULL
,	NULL
and	NULL
anti-lxBa	NULL
precipitated	NULL
only	NULL
a	NULL
trace	NULL
of	NULL
[	NULL
*	NULL
``	NULL
SJe-rel	NULL
or	NULL
p65	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
LPS	NULL
treatment	NULL
of	NULL
the	NULL
70	NULL
%	NULL
/3	NULL
pre-B	NULL
cells	NULL
resulted	NULL
in	NULL
loss	NULL
of	NULL
[	NULL
*°S	NULL
]	NULL
lxBa	NULL
from	NULL
c-rel-	NULL
and	NULL
p65-containing	NULL
complexes	NULL
.	NULL

At	NULL
the	NULL
same	NULL
time	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
precipitable	NULL
cytoplasmic	NULL
c-re/	NULL
and	NULL
p65	NULL
declined	NULL
somewhat	NULL
after	NULL
LPS	NULL
treatment	NULL
(	NULL
compare	NULL
lane	NULL
1	NULL
with	NULL
lane	NULL
4	NULL
,	NULL
and	NULL
lane	NULL
2	NULL
with	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
the	NULL
c-re/	NULL
and	NULL
p65	NULL
released	NULL
from	NULL
IxBa	NULL
left	NULL
the	NULL
cytoplasm	NULL
,	NULL
where	NULL
they	NULL
had	NULL
constituted	NULL
a	NULL
significant	NULL
fraction	NULL
of	NULL
total	NULL
c-rel	NULL
and	NULL
p65	NULL
.	NULL

There	NULL
are	NULL
two	NULL
additional	NULL
points	NULL
to	NULL
be	NULL
made	NULL
about	NULL
this	NULL
experiment	NULL
.	NULL

First	NULL
,	NULL
while	NULL
the	NULL
amount	NULL
of	NULL
[	NULL
*SJce-rel	NULL
and	NULL
[	NULL
}	NULL
°	NULL
$	NULL
]	NULL
p65	NULL
precipitable	NULL
by	NULL
anti-IxBa	NULL
after	NULL
LPS	NULL
treatment	NULL
was	NULL
very	NULL
low	NULL
,	NULL
it	NULL
was	NULL
not	NULL
zero	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

We	NULL
wondered	NULL
whether	NULL
this	NULL
low	NULL
level	NULL
represented	NULL
incomplete	NULL
dissociation	NULL
of	NULL
*°S-labeled	NULL
complexes	NULL
or	NULL
whether	NULL
it	NULL
reflected	NULL
binding	NULL
of	NULL
newly	NULL
synthesized	NULL
(	NULL
and	NULL
hence	NULL
non-radioactive	NULL
)	NULL
IxBa	NULL
to	NULL
c-re/	NULL
and	NULL
p65	NULL
.	NULL

To	NULL
test	NULL
this	NULL
,	NULL
LPS	NULL
treatment	NULL
was	NULL
carried	NULL
out	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
cycloheximide	NULL
.	NULL

The	NULL
result	NULL
was	NULL
that	NULL
precipitation	NULL
of	NULL
[	NULL
}	NULL
SlJce-rel	NULL
or	NULL
[	NULL
*S	NULL
]	NULL
p65	NULL
by	NULL
anti-lxBa	NULL
was	NULL
abolished	NULL
(	NULL
lane	NULL
10	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
synthesis	NULL
of	NULL
IxBa	NULL
proceeds	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
LPS	NULL
,	NULL
and	NULL
new	NULL
IxBa	NULL
is	NULL
able	NULL
to	NULL
associate	NULL
with	NULL
previously	NULL
synthesized	NULL
[	NULL
*SJc-rel	NULL
or	NULL
[	NULL
*°S	NULL
]	NULL
p65	NULL
.	NULL

Second	NULL
,	NULL
this	NULL
experiment	NULL
suggests	NULL
that	NULL
LPS	NULL
treatment	NULL
for	NULL
90	NULL
min	NULL
has	NULL
little	NULL
effect	NULL
on	NULL
processing	NULL
of	NULL
p105	NULL
and/or	NULL
p100	NULL
.	NULL

In	NULL
the	NULL
untreated	NULL
cells	NULL
,	NULL
both	NULL
the	NULL
c-re/	NULL
precipitate	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
and	NULL
the	NULL
p65	NULL
precipitate	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
contained	NULL
a	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
migrating	NULL
-IH-H-AA	NULL
1050	NULL
1051	NULL
1266	NULL
m-rel-I	NULL
m-rel-I	NULL
m-rel-C	NULL
Murine	NULL
c-rel	NULL
:	NULL
|	NULL
1158	NULL
I	NULL
rel-I	NULL
I	NULL
Human	NULL
c-re	NULL
!	NULL
}	NULL

I	NULL
I	NULL
I	NULL
1135	NULL
h-rel-I	NULL
pes	NULL
em	NULL
)	NULL
a	NULL
1207	NULL
]	NULL
1226	NULL
65-Nj	NULL
65-C	NULL
I	NULL
Murine	NULL
p105	NULL
I	NULL
i	NULL
I6	NULL
:	NULL
/f	NULL
IB	NULL
1263	NULL
|	NULL
1157	NULL
|	NULL
1140	NULL
m-105-N	NULL
|	NULL
105-I	NULL
|	NULL
105-C	NULL
«	NULL
&	NULL
rel	NULL
homology	NULL
region	NULL
-	NULL
#	NULL
»	NULL
!	NULL

IxBo	NULL
.	NULL

1258	NULL
MAD-3-C	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Antisera	NULL
.	NULL

The	NULL
diagram	NULL
shows	NULL
the	NULL
peptide	NULL
antisera	NULL
used	NULL
in	NULL
these	NULL
experiments	NULL
.	NULL

In	NULL
the	NULL
text	NULL
each	NULL
is	NULL
referred	NULL
to	NULL
generically	NULL
(	NULL
e.g	NULL
.	NULL

anti-c-re/	NULL
,	NULL
anti-p65	NULL
,	NULL
etc	NULL
.	NULL
)	NULL

,	NULL
then	NULL
by	NULL
its	NULL
specific	NULL
number	NULL
(	NULL
e.g	NULL
.	NULL

#	NULL
1158	NULL
,	NULL
#	NULL
1266	NULL
,	NULL
#	NULL
1207	NULL
,	NULL
etc	NULL
.	NULL
)	NULL

,	NULL
then	NULL
by	NULL
its	NULL
description	NULL
(	NULL
e.g	NULL
.	NULL

m-re/-I	NULL
,	NULL
for	NULL
murine	NULL
c-rel	NULL
internal	NULL
;	NULL
m-rel-C	NULL
,	NULL
for	NULL
murine	NULL
C-terminal	NULL
;	NULL
or	NULL
65-N	NULL
,	NULL
for	NULL
p65	NULL
N-terminal	NULL
)	NULL
.	NULL

Those	NULL
sera	NULL
without	NULL
an	NULL
'm	NULL
'	NULL
or	NULL
'	NULL
h	NULL
'	NULL
in	NULL
their	NULL
descriptive	NULL
name	NULL
recognize	NULL
murine	NULL
and	NULL
human	NULL
proteins	NULL
.	NULL

Each	NULL
serum	NULL
is	NULL
specific	NULL
for	NULL
its	NULL
protein	NULL
and	NULL
does	NULL
not	NULL
cross-react	NULL
with	NULL
other	NULL
family	NULL
members	NULL
.	NULL

4686	NULL
at	NULL
the	NULL
position	NULL
expected	NULL
of	NULL
p105	NULL
and	NULL
p100	NULL
(	NULL
which	NULL
co-migrate	NULL
under	NULL
our	NULL
conditions	NULL
)	NULL
.	NULL

This	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
was	NULL
also	NULL
present	NULL
,	NULL
in	NULL
about	NULL
the	NULL
same	NULL
amounts	NULL
,	NULL
after	NULL
LPS	NULL
treatment	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
of	NULL
the	NULL
known	NULL
inhibitors	NULL
that	NULL
bind	NULL
to	NULL
c-rel	NULL
and	NULL
p65	NULL
,	NULL
the	NULL
major	NULL
effect	NULL
of	NULL
LPS	NULL
is	NULL
on	NULL
IxBa	NULL
.	NULL

Of	NULL
course	NULL
we	NULL
can	NULL
not	NULL
rule	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
longer	NULL
treatment	NULL
or	NULL
a	NULL
different	NULL
stimulus	NULL
might	NULL
also	NULL
accelerate	NULL
processing	NULL
,	NULL
as	NULL
reported	NULL
for	NULL
phorbol	NULL
ester	NULL
treatment	NULL
of	NULL
HeLa	NULL
cells	NULL
(	NULL
Mercurio	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
these	NULL
results	NULL
are	NULL
unique	NULL
to	NULL
702/3	NULL
cells	NULL
,	NULL
a	NULL
similar	NULL
experiment	NULL
was	NULL
performed	NULL
with	NULL
WEHI	NULL
231	NULL
cells	NULL
,	NULL
where	NULL
levels	NULL
of	NULL
the	NULL
proteins	NULL
of	NULL
interest	NULL
are	NULL
much	NULL
higher	NULL
.	NULL

With	NULL
one	NULL
exception	NULL
,	NULL
results	NULL
were	NULL
much	NULL
like	NULL
those	NULL
seen	NULL
with	NULL
7027/3	NULL
cells	NULL
.	NULL

As	NULL
above	NULL
,	NULL
WEHI	NULL
231	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
S-containing	NULL
medium	NULL
,	NULL
then	NULL
in	NULL
non-radioactive	NULL
medium	NULL
with	NULL
A	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

LPS	NULL
results	NULL
in	NULL
loss	NULL
of	NULL
IxBa	NULL
.	NULL

(	NULL
A	NULL
)	NULL
702/3	NULL
cells	NULL
were	NULL
grown	NULL
for	NULL
1	NULL
h	NULL
in	NULL
medium	NULL
containing	NULL
[	NULL
*5S	NULL
)	NULL
methionine	NULL
and	NULL
(	NULL
each	NULL
at	NULL
100	NULL
Ci	NULL
per	NULL
ml	NULL
)	NULL
.	NULL

Excess	NULL
unlabeled	NULL
methionine	NULL
and	NULL
cysteine	NULL
were	NULL
then	NULL
added	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
diluted	NULL
10-fold	NULL
into	NULL
complete	NULL
medium	NULL
containing	NULL
LPS	NULL
(	NULL
15	NULL
pg/ml	NULL
)	NULL
,	NULL
LPS	NULL
plus	NULL
cycloheximide	NULL
(	NULL
20	NULL
pg/ml	NULL
!	NULL
)	NULL

or	NULL
no	NULL
additives	NULL
.	NULL

After	NULL
90	NULL
min	NULL
,	NULL
cytoplasmic	NULL
extracts	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
anti-c-re/	NULL
(	NULL
#	NULL
1051	NULL
,	NULL
m-re/-I	NULL
)	NULL
and	NULL
anti-p65	NULL
(	NULL
#	NULL
1226	NULL
,	NULL
65-C	NULL
)	NULL
.	NULL

The	NULL
precipitates	NULL
were	NULL
eluted	NULL
with	NULL
excess	NULL
peptides	NULL
,	NULL
and	NULL
the	NULL
eluates	NULL
were	NULL
reprecipitated	NULL
with	NULL
anti-c-re/	NULL
(	NULL
#	NULL
1050	NULL
,	NULL
m-re/-D	NULL
,	NULL
anti-p65	NULL
(	NULL
#	NULL
1207	NULL
,	NULL
65-N	NULL
)	NULL
or	NULL
anti-IxBa	NULL
(	NULL
#	NULL
1258	NULL
,	NULL
MAD-3C	NULL
)	NULL
,	NULL
as	NULL
indicated	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

Each	NULL
lane	NULL
contains	NULL
the	NULL
precipitate	NULL
from	NULL
~10	NULL
``	NULL
cells	NULL
.	NULL

The	NULL
film	NULL
was	NULL
exposed	NULL
for	NULL
30	NULL
days	NULL
.	NULL

(	NULL
B	NULL
)	NULL
WEHI	NULL
231	NULL
cells	NULL
were	NULL
treated	NULL
as	NULL
in	NULL
(	NULL
A	NULL
)	NULL
.	NULL

Cytoplasmic	NULL
extracts	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-c-re/	NULL
(	NULL
#	NULL
1050	NULL
,	NULL
m-re/-D	NULL
)	NULL
.	NULL

Precipitates	NULL
were	NULL
eluted	NULL
with	NULL
peptide	NULL
,	NULL
and	NULL
eluates	NULL
were	NULL
reprecipitated	NULL
with	NULL
anti-c-re/	NULL
(	NULL
#	NULL
1051	NULL
,	NULL
m-rel-D	NULL
)	NULL
,	NULL
anti-IxBa	NULL
(	NULL
#	NULL
1258	NULL
,	NULL
MAD-3-C	NULL
)	NULL
or	NULL
anti-p105	NULL
(	NULL
#	NULL
1263	NULL
,	NULL
m-105-N	NULL
)	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

Each	NULL
lane	NULL
contains	NULL
the	NULL
preciptate	NULL
from	NULL
~10	NULL
``	NULL
cells	NULL
.	NULL

The	NULL
film	NULL
was	NULL
exposed	NULL
for	NULL
3	NULL
days	NULL
.	NULL

Instability	NULL
of	NULL
IxBa	NULL
complexes	NULL
and	NULL
without	NULL
LPS	NULL
.	NULL

Cytoplasmic	NULL
extracts	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-c-re/	NULL
,	NULL
precipitates	NULL
were	NULL
eluted	NULL
with	NULL
peptide	NULL
,	NULL
and	NULL
eluates	NULL
were	NULL
reprecipitated	NULL
as	NULL
shown	NULL
in	NULL
Figure	NULL
2B	NULL
.	NULL

In	NULL
extracts	NULL
from	NULL
the	NULL
untreated	NULL
cells	NULL
,	NULL
anti-c-re/	NULL
precipitated	NULL
[	NULL
*°S	NULL
]	NULL
IxBa	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
and	NULL
anti-IxBa	NULL
precipitated	NULL
and	NULL
[	NULL
*°SJc-rel	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
just	NULL
as	NULL
in	NULL
the	NULL
70Z/3	NULL
experiment	NULL
.	NULL

LPS	NULL
treatment	NULL
resulted	NULL
in	NULL
the	NULL
loss	NULL
of	NULL
[	NULL
*°S	NULL
]	NULL
lxBa	NULL
from	NULL
the	NULL
rel	NULL
precipitate	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
but	NULL
,	NULL
unlike	NULL
the	NULL
result	NULL
with	NULL
702/3	NULL
cells	NULL
,	NULL
anti-lxBa	NULL
was	NULL
still	NULL
able	NULL
to	NULL
precipitate	NULL
considerable	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
while	NULL
LPS	NULL
caused	NULL
the	NULL
loss	NULL
of	NULL
[	NULL
*°S	NULL
]	NULL
IxBa	NULL
,	NULL
replacement	NULL
by	NULL
new	NULL
unlabeled	NULL
IxBa	NULL
must	NULL
have	NULL
been	NULL
so	NULL
rapid	NULL
that	NULL
much	NULL
of	NULL
the	NULL
temporarily	NULL
liberated	NULL
[	NULL
*S	NULL
)	NULL
c-re/	NULL
remained	NULL
precipitable	NULL
by	NULL
anti-IxBa	NULL
.	NULL

As	NULL
above	NULL
,	NULL
this	NULL
interpretation	NULL
was	NULL
confirmed	NULL
by	NULL
treating	NULL
with	NULL
LPS	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
cycloheximide	NULL
.	NULL

Under	NULL
those	NULL
conditions	NULL
,	NULL
not	NULL
only	NULL
did	NULL
[	NULL
3°S	NULL
]	NULL
IxBa	NULL
dissociate	NULL
from	NULL
c-rel	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
but	NULL
also	NULL
anti-IxBa	NULL
was	NULL
unable	NULL
to	NULL
precipitate	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
as	NULL
in	NULL
7027/3	NULL
cells	NULL
,	NULL
synthesis	NULL
of	NULL
IxBa	NULL
continued	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
LPS	NULL
,	NULL
and	NULL
newly	NULL
synthesized	NULL
molecules	NULL
were	NULL
able	NULL
to	NULL
associate	NULL
with	NULL
pre-existing	NULL
but	NULL
newly	NULL
liberated	NULL
[	NULL
*°SJc-rel	NULL
.	NULL

This	NULL
strongly	NULL
suggests	NULL
(	NULL
i	NULL
)	NULL
that	NULL
the	NULL
LPS	NULL
signal	NULL
affects	NULL
IxBa	NULL
complexes	NULL
rather	NULL
than	NULL
free	NULL
IxBa	NULL
,	NULL
i.e	NULL
.	NULL

the	NULL
signal	NULL
causes	NULL
disruption	NULL
of	NULL
complexes	NULL
rather	NULL
than	NULL
preventing	NULL
their	NULL
formation	NULL
,	NULL
and	NULL
(	NULL
ii	NULL
)	NULL
that	NULL
disruption	NULL
results	NULL
from	NULL
some	NULL
change	NULL
to	NULL
IxBa	NULL
,	NULL
not	NULL
to	NULL
c-rel	NULL
,	NULL
since	NULL
[	NULL
*°S	NULL
}	NULL
c-rel	NULL
remained	NULL
able	NULL
to	NULL
bind	NULL
to	NULL
new	NULL
inhibitor	NULL
molecules	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
this	NULL
experiment	NULL
shows	NULL
that	NULL
translocation	NULL
to	NULL
the	NULL
nucleus	NULL
is	NULL
not	NULL
a	NULL
necessary	NULL
consequence	NULL
of	NULL
every	NULL
dissociation	NULL
event	NULL
.	NULL

If	NULL
new	NULL
IxBa	NULL
is	NULL
synthesized	NULL
at	NULL
a	NULL
high	NULL
enough	NULL
rate	NULL
[	NULL
and	NULL
90	NULL
min	NULL
exposure	NULL
to	NULL
at	NULL
least	NULL
some	NULL
activating	NULL
agents	NULL
is	NULL
sufficient	NULL
to	NULL
increase	NULL
the	NULL
level	NULL
of	NULL
IxBa	NULL
mRNA	NULL
significantly	NULL
(	NULL
Haskill	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Brown	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Sun	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
]	NULL
dissociated	NULL
rel	NULL
and/or	NULL
p65	NULL
may	NULL
be	NULL
efficiently	NULL
recaptured	NULL
and	NULL
retained	NULL
in	NULL
the	NULL
cytoplasm	NULL
.	NULL

We	NULL
wondered	NULL
whether	NULL
the	NULL
[	NULL
*°S	NULL
]	NULL
lxBa	NULL
that	NULL
disappears	NULL
from	NULL
c-rel	NULL
complexes	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
could	NULL
be	NULL
found	NULL
as	NULL
free	NULL
molecules	NULL
.	NULL

This	NULL
was	NULL
tested	NULL
by	NULL
exhaustively	NULL
precipitating	NULL
the	NULL
cytoplasmic	NULL
extract	NULL
from	NULL
LPS-treated	NULL
WEHI	NULL
231	NULL
cells	NULL
with	NULL
anti-c-re/	NULL
and	NULL
anti-p65	NULL
,	NULL
and	NULL
then	NULL
looking	NULL
for	NULL
[	NULL
*5S	NULL
]	NULL
IxBa	NULL
:	NULL
in	NULL
the	NULL
supernatant	NULL
.	NULL

None	NULL
was	NULL
detectable	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
it	NULL
had	NULL
been	NULL
degraded	NULL
.	NULL

The	NULL
same	NULL
result	NULL
was	NULL
obtained	NULL
with	NULL
two	NULL
different	NULL
IxBa	NULL
antibodies	NULL
,	NULL
neither	NULL
of	NULL
which	NULL
was	NULL
directed	NULL
at	NULL
a	NULL
region	NULL
with	NULL
a	NULL
potential	NULL
phosphorylation	NULL
site	NULL
.	NULL

As	NULL
with	NULL
the	NULL
702/3	NULL
cells	NULL
,	NULL
there	NULL
was	NULL
no	NULL
obvious	NULL
effect	NULL
of	NULL
LPS	NULL
treatment	NULL
on	NULL
processing	NULL
of	NULL
pre-existing	NULL
p105	NULL
.	NULL

A	NULL
high	NULL
molecular	NULL
weight	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
coprecipitated	NULL
with	NULL
c-rel	NULL
in	NULL
both	NULL
untreated	NULL
and	NULL
LPS-treated	NULL
cells	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
4	NULL
)	NULL
;	NULL
presumably	NULL
it	NULL
represents	NULL
a	NULL
combination	NULL
of	NULL
p105	NULL
and	NULL
p100	NULL
.	NULL

When	NULL
the	NULL
rel-containing	NULL
complexes	NULL
were	NULL
reprecipitated	NULL
with	NULL
anti-p105	NULL
,	NULL
bands	NULL
of	NULL
similar	NULL
intensity	NULL
were	NULL
seen	NULL
in	NULL
treated	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
and	NULL
untreated	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
cells	NULL
.	NULL

LPS	NULL
treatment	NULL
increases	NULL
nuclear	NULL
c-rel	NULL
and	NULL
p6S	NULL
The	NULL
preceding	NULL
experiments	NULL
showed	NULL
that	NULL
LPS	NULL
treatment	NULL
resulted	NULL
in	NULL
loss	NULL
of	NULL
IxBa	NULL
from	NULL
c-re/-containing	NULL
cytoplasmic	NULL
complexes	NULL
.	NULL

We	NULL
next	NULL
tested	NULL
whether	NULL
dissociation	NULL
outpaced	NULL
replacement	NULL
sufficiently	NULL
to	NULL
allow	NULL
some	NULL
liberated	NULL
complexes	NULL
to	NULL
reach	NULL
the	NULL
nucleus	NULL
.	NULL

702	NULL
%	NULL
/3	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
LPS	NULL
,	NULL
and	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
extracts	NULL
were	NULL
assayed	NULL
by	NULL
immunoblotting	NULL
(	NULL
Figure	NULL
3A	NULL
)	NULL
.	NULL

In	NULL
untreated	NULL
cells	NULL
there	NULL
was	NULL
little	NULL
nuclear	NULL
p50	NULL
,	NULL
p65	NULL
or	NULL
c-rel	NULL
,	NULL
but	NULL
the	NULL
level	NULL
of	NULL
all	NULL
three	NULL
increased	NULL
significantly	NULL
upon	NULL
LPS	NULL
treatment	NULL
.	NULL

Most	NULL
p50	NULL
and	NULL
p6S	NULL
remained	NULL
in	NULL
the	NULL
cytoplasm	NULL
even	NULL
after	NULL
treatment	NULL
4687	NULL
tam	NULL
o	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Effect	NULL
of	NULL
LPS	NULL
on	NULL
nuclear	NULL
c-re/	NULL
and	NULL
p65	NULL
and	NULL
on	NULL
DNA-binding	NULL
activity	NULL
.	NULL

(	NULL
A	NULL
)	NULL
702/3	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
LPS	NULL
(	NULL
15	NULL
ug/ml	NULL
!	NULL
)	NULL

for	NULL
85	NULL
min	NULL
or	NULL
were	NULL
left	NULL
untreated	NULL
.	NULL

Nuclear	NULL
and	NULL
cytoplasmic	NULL
extracts	NULL
were	NULL
assayed	NULL
by	NULL
immunoblotting	NULL
using	NULL
anti-c-re/	NULL
(	NULL
#	NULL
1050	NULL
,	NULL
m-re/-D	NULL
,	NULL
anti-p65	NULL
(	NULL
#	NULL
1226	NULL
,	NULL
65-C	NULL
)	NULL
or	NULL
anti-p50	NULL
(	NULL
#	NULL
1157	NULL
,	NULL
105-1	NULL
)	NULL
.	NULL

Each	NULL
lane	NULL
contains	NULL
extract	NULL
from	NULL
2.6	NULL
%	NULL
106	NULL
cells	NULL
(	NULL
rel	NULL
,	NULL
p65	NULL
)	NULL
or	NULL
1.4	NULL
x	NULL
106	NULL
cells	NULL
(	NULL
pSO	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
702/3	NULL
and	NULL
WEHI	NULL
231	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
LPS	NULL
(	NULL
10	NULL
ug/ml	NULL
!	NULL
)	NULL

for	NULL
90	NULL
min	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
treated	NULL
and	NULL
untreated	NULL
cells	NULL
were	NULL
assayed	NULL
for	NULL
ability	NULL
to	NULL
bind	NULL
to	NULL
a	NULL
+°P-labeled	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
murine	NULL
kappa	NULL
chain	NULL
intronic	NULL
xB	NULL
site	NULL
.	NULL

Unbound	NULL
probe	NULL
migrated	NULL
to	NULL
the	NULL
bottom	NULL
of	NULL
the	NULL
gel	NULL
and	NULL
is	NULL
not	NULL
shown	NULL
in	NULL
the	NULL
figure	NULL
.	NULL

(	NULL
C	NULL
)	NULL
702/3	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
LPS	NULL
,	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
assayed	NULL
as	NULL
in	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Prior	NULL
to	NULL
incubation	NULL
with	NULL
the	NULL
32P-labeled	NULL
probe	NULL
,	NULL
samples	NULL
were	NULL
incubated	NULL
with	NULL
anti-c-re/	NULL
(	NULL
#	NULL
1051	NULL
,	NULL
m-rel-I	NULL
,	NULL
lane	NULL
3	NULL
;	NULL
or	NULL
#	NULL
1266	NULL
,	NULL
m-rel-C	NULL
,	NULL
lane	NULL
9	NULL
)	NULL
,	NULL
anti-p50	NULL
(	NULL
#	NULL
1263	NULL
,	NULL
m-105-N	NULL
;	NULL
lane	NULL
4	NULL
)	NULL
or	NULL
anti-p65	NULL
(	NULL
#	NULL
1226	NULL
,	NULL
65-C	NULL
;	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Samples	NULL
in	NULL
lanes	NULL
5	NULL
and	NULL
10	NULL
contained	NULL
32P-labeled	NULL
probe	NULL
and	NULL
antiserum	NULL
,	NULL
but	NULL
no	NULL
nuclear	NULL
extract	NULL
.	NULL

For	NULL
lanes	NULL
2	NULL
and	NULL
8	NULL
,	NULL
the	NULL
incubation	NULL
mixture	NULL
included	NULL
a	NULL
40-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
xB	NULL
oligonucleotide	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Nuclear	NULL
extract	NULL
from	NULL
WEHI	NULL
231	NULL
cells	NULL
was	NULL
assayed	NULL
for	NULL
DNA-binding	NULL
activity	NULL
using	NULL
a	NULL
32P-labeled	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
IL-6	NULL
xB	NULL
site	NULL
.	NULL

Prior	NULL
to	NULL
addition	NULL
of	NULL
the	NULL
32P-labeled	NULL
probe	NULL
,	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
anti-c-re/	NULL
(	NULL
#	NULL
1266	NULL
,	NULL
m-rel-C	NULL
;	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
anti-p65	NULL
(	NULL
#	NULL
1226	NULL
,	NULL
65-C	NULL
;	NULL
lane	NULL
4	NULL
)	NULL
or	NULL
anti-p50	NULL
(	NULL
#	NULL
1263	NULL
,	NULL
m-105-N	NULL
;	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

The	NULL
sample	NULL
in	NULL
lane	NULL
6	NULL
contained	NULL
P-labeled	NULL
probe	NULL
and	NULL
anti-c-rel	NULL
,	NULL
but	NULL
no	NULL
nuclear	NULL
extract	NULL
.	NULL

For	NULL
lane	NULL
2	NULL
,	NULL
the	NULL
incubation	NULL
mixture	NULL
included	NULL
a	NULL
200-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
xB	NULL
oligonucleotide	NULL
.	NULL

(	NULL
reflecting	NULL
not	NULL
only	NULL
IxBa-containing	NULL
complexes	NULL
,	NULL
but	NULL
those	NULL
significantly	NULL
more	NULL
binding	NULL
activity	NULL
in	NULL
LPS-stimulated	NULL
than	NULL
with	NULL
p105	NULL
and	NULL
p100	NULL
as	NULL
well	NULL
)	NULL
,	NULL
but	NULL
the	NULL
amount	NULL
of	NULL
c-re	NULL
!	NULL

is	NULL
low	NULL
in	NULL
unstimulated	NULL
702/3	NULL
cells	NULL
(	NULL
Figure	NULL
3B	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

In	NULL
enough	NULL
in	NULL
these	NULL
cells	NULL
that	NULL
transport	NULL
to	NULL
the	NULL
nucleus	NULL
diminished	NULL
contrast	NULL
,	NULL
WEHI	NULL
231	NULL
cells	NULL
had	NULL
a	NULL
high	NULL
level	NULL
of	NULL
activity	NULL
in	NULL
the	NULL
cytoplasmic	NULL
level	NULL
noticeably	NULL
.	NULL

With	NULL
WEHI	NULL
231	NULL
cells	NULL
the	NULL
unstimulated	NULL
cells	NULL
[	NULL
as	NULL
has	NULL
been	NULL
reported	NULL
previously	NULL
(	NULL
Sen	NULL
and	NULL
results	NULL
were	NULL
similar	NULL
,	NULL
except	NULL
that	NULL
even	NULL
untreated	NULL
cells	NULL
had	NULL
Baltimore	NULL
,	NULL
1986b	NULL
;	NULL
Inoue	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
]	NULL
.	NULL

This	NULL
constitutive	NULL
some	NULL
nuclear	NULL
c-re/	NULL
and	NULL
p50	NULL
.	NULL

The	NULL
levels	NULL
of	NULL
nuclear	NULL
c-re/	NULL
and	NULL
level	NULL
was	NULL
so	NULL
high	NULL
that	NULL
it	NULL
did	NULL
not	NULL
increase	NULL
significantly	NULL
upon	NULL
p65	NULL
were	NULL
increased	NULL
appreciably	NULL
by	NULL
LPS	NULL
treatment	NULL
(	NULL
data	NULL
not	NULL
LPS	NULL
treatment	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
,	NULL
in	NULL
spite	NULL
of	NULL
the	NULL
fact	NULL
that	NULL
shown	NULL
)	NULL
.	NULL

immunoblot	NULL
analysis	NULL
had	NULL
shown	NULL
increased	NULL
nuclear	NULL
c-re/	NULL
and	NULL
p65	NULL
in	NULL
LPS-treated	NULL
cells	NULL
.	NULL

LPS-induced	NULL
DNA	NULL
binding	NULL
activity	NULL
To	NULL
determine	NULL
the	NULL
composition	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
We	NULL
next	NULL
tested	NULL
whether	NULL
the	NULL
increased	NULL
level	NULL
of	NULL
nuclear	NULL
rel	NULL
complexes	NULL
,	NULL
their	NULL
reactivity	NULL
with	NULL
various	NULL
rel	NULL
family	NULL
antisera	NULL
family	NULL
members	NULL
would	NULL
be	NULL
reflected	NULL
in	NULL
increased	NULL
DNA	NULL
was	NULL
tested	NULL
.	NULL

Both	NULL
of	NULL
the	NULL
prominent	NULL
bands	NULL
produced	NULL
by	NULL
the	NULL
binding	NULL
activity	NULL
.	NULL

702/3	NULL
and	NULL
WEHI	NULL
231	NULL
cells	NULL
were	NULL
treated	NULL
7027/3	NULL
extracts	NULL
were	NULL
shifted	NULL
by	NULL
anti-p50	NULL
(	NULL
Figure	NULL
3C	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
with	NULL
LPS	NULL
for	NULL
90	NULL
min	NULL
,	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
assayed	NULL
for	NULL
while	NULL
only	NULL
the	NULL
upper	NULL
band	NULL
was	NULL
shifted	NULL
by	NULL
anti-p65	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

their	NULL
ability	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
xB	NULL
site	NULL
from	NULL
the	NULL
intron	NULL
enhancer	NULL
Anti-c-rel	NULL
had	NULL
little	NULL
or	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
bound	NULL
complexes	NULL
of	NULL
the	NULL
murine	NULL
kappa	NULL
light	NULL
chain	NULL
gene	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

In	NULL
a	NULL
second	NULL
experiment	NULL
using	NULL
a	NULL
different	NULL
anti-c-re/	NULL
results	NULL
of	NULL
others	NULL
(	NULL
Sen	NULL
and	NULL
Baltimore	NULL
,	NULL
1986b	NULL
)	NULL
,	NULL
there	NULL
was	NULL
serum	NULL
,	NULL
however	NULL
,	NULL
a	NULL
small	NULL
amount	NULL
of	NULL
shifted	NULL
material	NULL
was	NULL
seen	NULL
4688	NULL
Instability	NULL
of	NULL
IxBa	NULL
complexes	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

IxBa	NULL
has	NULL
a	NULL
short	NULL
half-life	NULL
.	NULL

(	NULL
A	NULL
)	NULL
WEHI	NULL
231	NULL
cells	NULL
were	NULL
grown	NULL
for	NULL
1	NULL
h	NULL
in	NULL
medium	NULL
containing	NULL
[	NULL
35S	NULL
)	NULL
Jmethionine	NULL
and	NULL
[	NULL
35S	NULL
)	NULL
cysteine	NULL
(	NULL
each	NULL
at	NULL
100	NULL
uCi	NULL
per	NULL
ml	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
pelleted	NULL
,	NULL
resuspended	NULL
in	NULL
non-radioactive	NULL
complete	NULL
medium	NULL
,	NULL
and	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

Whole	NULL
cell	NULL
extracts	NULL
were	NULL
adjusted	NULL
to	NULL
1	NULL
%	NULL
SDS	NULL
and	NULL
0.5	NULL
%	NULL
B-mercaptoethanol	NULL
and	NULL
boiled	NULL
for	NULL
5	NULL
min	NULL
.	NULL

After	NULL
diluting	NULL
at	NULL
least	NULL
4-fold	NULL
with	NULL
TNT-E	NULL
buffer	NULL
,	NULL
aliquots	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-IxBa	NULL
(	NULL
#	NULL
1258	NULL
,	NULL
MAD-3-C	NULL
)	NULL
.	NULL

The	NULL
sample	NULL
shown	NULL
in	NULL
lane	NULL
2	NULL
contained	NULL
competing	NULL
peptide	NULL
1258	NULL
.	NULL

Each	NULL
lane	NULL
contains	NULL
precipitate	NULL
from	NULL
~3	NULL
x	NULL
106	NULL
cells	NULL
and	NULL
the	NULL
film	NULL
was	NULL
exposed	NULL
for	NULL
6	NULL
days	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
treated	NULL
as	NULL
in	NULL
A	NULL
,	NULL
except	NULL
that	NULL
the	NULL
*5S-containing	NULL
medium	NULL
was	NULL
not	NULL
removed	NULL
following	NULL
the	NULL
labeling	NULL
period	NULL
.	NULL

Instead	NULL
,	NULL
excess	NULL
unlabeled	NULL
methionine	NULL
and	NULL
cysteine	NULL
were	NULL
added	NULL
,	NULL
and	NULL
cells	NULL
were	NULL
diluted	NULL
5-fold	NULL
into	NULL
complete	NULL
medium	NULL
.	NULL

To	NULL
reduce	NULL
background	NULL
on	NULL
the	NULL
gel	NULL
,	NULL
immunoprecipitation	NULL
was	NULL
performed	NULL
in	NULL
two	NULL
steps	NULL
.	NULL

Lysate	NULL
(	NULL
obtained	NULL
as	NULL
in	NULL
A	NULL
)	NULL
was	NULL
precipitated	NULL
with	NULL
anti-IxBa	NULL
(	NULL
#	NULL
1258	NULL
,	NULL
MAD-3-C	NULL
)	NULL
.	NULL

Precipitates	NULL
were	NULL
washed	NULL
with	NULL
TNT	NULL
buffer	NULL
,	NULL
boiled	NULL
in	NULL
1	NULL
%	NULL
SDS	NULL
for	NULL
5	NULL
min	NULL
,	NULL
diluted	NULL
at	NULL
least	NULL
4-fold	NULL
with	NULL
TNT	NULL
and	NULL
then	NULL
reprecipitated	NULL
with	NULL
fresh	NULL
anti-IxBa	NULL
.	NULL

Samples	NULL
in	NULL
lanes	NULL
2	NULL
,	NULL
4	NULL
,	NULL
6	NULL
and	NULL
8	NULL
contained	NULL
competing	NULL
peptide	NULL
1258	NULL
during	NULL
the	NULL
second	NULL
precipitation	NULL
.	NULL

Each	NULL
lane	NULL
contains	NULL
precipitate	NULL
from	NULL
~9	NULL
x	NULL
106	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
film	NULL
was	NULL
exposed	NULL
for	NULL
7	NULL
days	NULL
.	NULL

(	NULL
lane	NULL
9	NULL
,	NULL
arrow	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
upper	NULL
band	NULL
must	NULL
be	NULL
composed	NULL
predominantly	NULL
of	NULL
a	NULL
p50/p65	NULL
heterodimer	NULL
,	NULL
but	NULL
may	NULL
also	NULL
contain	NULL
some	NULL
c-rel/p50	NULL
,	NULL
while	NULL
the	NULL
lower	NULL
band	NULL
is	NULL
either	NULL
a	NULL
p50/p50	NULL
homodimer	NULL
or	NULL
a	NULL
p50/pS52	NULL
heterodimer	NULL
(	NULL
or	NULL
both	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
c-ref	NULL
in	NULL
WEHI	NULL
231	NULL
nuclear	NULL
extracts	NULL
bound	NULL
very	NULL
well	NULL
to	NULL
xB-containing	NULL
probes	NULL
.	NULL

A	NULL
significant	NULL
fraction	NULL
of	NULL
the	NULL
total	NULL
bound	NULL
complex	NULL
was	NULL
shifted	NULL
by	NULL
anti-c-re/	NULL
(	NULL
Figure	NULL
3D	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
while	NULL
little	NULL
or	NULL
none	NULL
was	NULL
shifted	NULL
by	NULL
anti-p65	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

All	NULL
of	NULL
it	NULL
was	NULL
shifted	NULL
by	NULL
anti-p50	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

Thus	NULL
WEHI	NULL
231	NULL
extracts	NULL
contain	NULL
a	NULL
prominent	NULL
p50/c-rel	NULL
heterodimer	NULL
,	NULL
as	NULL
well	NULL
as	NULL
other	NULL
unidentified	NULL
p50-containing	NULL
complexes	NULL
(	NULL
with	NULL
rel	NULL
B	NULL
?	NULL

p52	NULL
?	NULL
)	NULL

.	NULL

There	NULL
was	NULL
no	NULL
change	NULL
in	NULL
this	NULL
pattern	NULL
with	NULL
extracts	NULL
from	NULL
LPS-treated	NULL
cells	NULL
:	NULL
the	NULL
nuclear	NULL
p65	NULL
detected	NULL
by	NULL
immunoblot	NULL
analysis	NULL
did	NULL
not	NULL
contribute	NULL
significantly	NULL
to	NULL
the	NULL
total	NULL
DNA-binding	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
LPS	NULL
treatment	NULL
of	NULL
7027/3	NULL
and	NULL
WEHI	NULL
231	NULL
cells	NULL
resulted	NULL
in	NULL
loss	NULL
of	NULL
IxBa	NULL
from	NULL
all	NULL
pre-existing	NULL
c-re/-	NULL
or	NULL
p65-containing	NULL
complexes	NULL
.	NULL

Most	NULL
,	NULL
but	NULL
not	NULL
all	NULL
,	NULL
of	NULL
the	NULL
liberated	NULL
c-rel	NULL
and	NULL
p65	NULL
was	NULL
transported	NULL
to	NULL
the	NULL
nucleus	NULL
in	NULL
702/3	NULL
cells	NULL
,	NULL
where	NULL
they	NULL
were	NULL
detectable	NULL
both	NULL
by	NULL
immunoblotting	NULL
and	NULL
by	NULL
DNA	NULL
binding	NULL
assays	NULL
.	NULL

In	NULL
WEHI	NULL
231	NULL
cells	NULL
some	NULL
of	NULL
the	NULL
liberated	NULL
c-rel	NULL
and	NULL
p65	NULL
reached	NULL
the	NULL
nucleus	NULL
,	NULL
but	NULL
most	NULL
appeared	NULL
to	NULL
be	NULL
bound	NULL
to	NULL
newly	NULL
synthesized	NULL
IxBa	NULL
and	NULL
retained	NULL
in	NULL
the	NULL
cytoplasm	NULL
.	NULL

IxBa	NULL
has	NULL
a	NULL
short	NULL
half-life	NULL
The	NULL
preceding	NULL
experiments	NULL
showed	NULL
that	NULL
disruption	NULL
of	NULL
IxBa	NULL
complexes	NULL
occurred	NULL
upon	NULL
activation	NULL
of	NULL
the	NULL
cell	NULL
.	NULL

We	NULL
wondered	NULL
whether	NULL
dissociation	NULL
also	NULL
occurs	NULL
at	NULL
a	NULL
lower	NULL
but	NULL
significant	NULL
rate	NULL
in	NULL
the	NULL
unstimulated	NULL
cell	NULL
.	NULL

This	NULL
question	NULL
was	NULL
prompted	NULL
by	NULL
the	NULL
observations	NULL
that	NULL
in	NULL
pre-B	NULL
cells	NULL
cycloheximide	NULL
alone	NULL
results	NULL
in	NULL
both	NULL
nuclear	NULL
xB	NULL
binding	NULL
activity	NULL
(	NULL
Sen	NULL
and	NULL
Baltimore	NULL
,	NULL
1986b	NULL
)	NULL
and	NULL
transcription	NULL
of	NULL
the	NULL
kappa	NULL
light	NULL
chain	NULL
gene	NULL
(	NULL
Wall	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
)	NULL
.	NULL

Both	NULL
of	NULL
these	NULL
studies	NULL
suggest	NULL
that	NULL
there	NULL
is	NULL
a	NULL
short-lived	NULL
protein	NULL
inhibitor	NULL
of	NULL
kappa	NULL
gene	NULL
expression	NULL
.	NULL

If	NULL
the	NULL
labile	NULL
protein	NULL
is	NULL
IxBa	NULL
,	NULL
then	NULL
dissociation	NULL
of	NULL
IxBa	NULL
complexes	NULL
may	NULL
be	NULL
a	NULL
frequent	NULL
occurrence	NULL
and	NULL
not	NULL
limited	NULL
to	NULL
periods	NULL
of	NULL
cellular	NULL
activation	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
stability	NULL
of	NULL
IxBa	NULL
,	NULL
WEHI	NULL
231	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
medium	NULL
containing	NULL
[	NULL
°*°S	NULL
)	NULL
methionine	NULL
and	NULL
[	NULL
}	NULL
5S	NULL
}	NULL
cysteine	NULL
for	NULL
1	NULL
h	NULL
and	NULL
then	NULL
in	NULL
non-radioactive	NULL
medium	NULL
for	NULL
varying	NULL
times	NULL
.	NULL

Total	NULL
cell	NULL
extract	NULL
was	NULL
boiled	NULL
in	NULL
SDS	NULL
,	NULL
precipitated	NULL
with	NULL
anti-IxBa	NULL
and	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

The	NULL
intensely	NULL
labeled	NULL
protein	NULL
band	NULL
seen	NULL
in	NULL
the	NULL
pulse-labeled	NULL
sample	NULL
(	NULL
Figure	NULL
4A	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
was	NULL
nearly	NULL
gone	NULL
after	NULL
2	NULL
h	NULL
of	NULL
chase	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
and	NULL
continued	NULL
to	NULL
decline	NULL
thereafter	NULL
(	NULL
lanes	NULL
4-6	NULL
)	NULL
.	NULL

The	NULL
same	NULL
result	NULL
was	NULL
obtained	NULL
with	NULL
three	NULL
different	NULL
IxBa	NULL
antibodies	NULL
directed	NULL
at	NULL
different	NULL
regions	NULL
of	NULL
the	NULL
protein	NULL
.	NULL

This	NULL
result	NULL
shows	NULL
that	NULL
in	NULL
these	NULL
murine	NULL
B	NULL
cells	NULL
total	NULL
cellular	NULL
IxBa	NULL
turns	NULL
over	NULL
very	NULL
rapidly	NULL
.	NULL

From	NULL
multiple	NULL
experiments	NULL
we	NULL
estimate	NULL
a	NULL
half-life	NULL
of	NULL
~30	NULL
min	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
this	NULL
result	NULL
is	NULL
unique	NULL
to	NULL
B	NULL
cells	NULL
,	NULL
in	NULL
which	NULL
NF-xB	NULL
is	NULL
active	NULL
constitutively	NULL
,	NULL
similar	NULL
experiments	NULL
were	NULL
performed	NULL
with	NULL
the	NULL
murine	NULL
pre-B	NULL
cell	NULL
line	NULL
702	NULL
%	NULL
/3	NULL
(	NULL
propagated	NULL
in	NULL
either	NULL
serum-free	NULL
or	NULL
serum-containing	NULL
medium	NULL
)	NULL
,	NULL
the	NULL
human	NULL
plasmacytoma	NULL
cell	NULL
line	NULL
Sultan	NULL
,	NULL
the	NULL
human	NULL
T	NULL
cell	NULL
line	NULL
Jurkat	NULL
and	NULL
the	NULL
human	NULL
epithelial	NULL
cell	NULL
line	NULL
HeLa	NULL
.	NULL

The	NULL
results	NULL
showed	NULL
that	NULL
IxBa	NULL
turns	NULL
over	NULL
rapidly	NULL
in	NULL
these	NULL
cells	NULL
as	NULL
well	NULL
.	NULL

In	NULL
all	NULL
cases	NULL
the	NULL
half-life	NULL
of	NULL
IxBa	NULL
was	NULL
~1	NULL
h	NULL
(	NULL
Figure	NULL
4B	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Most	NULL
IxBa	NULL
is	NULL
complexed	NULL
to	NULL
rel	NULL
and/or	NULL
p65	NULL
The	NULL
preceding	NULL
experiments	NULL
measured	NULL
the	NULL
stability	NULL
of	NULL
total	NULL
cellular	NULL
IxBa	NULL
.	NULL

They	NULL
leave	NULL
open	NULL
the	NULL
possibility	NULL
that	NULL
there	NULL
is	NULL
a	NULL
rapidly	NULL
turning	NULL
over	NULL
pool	NULL
of	NULL
free	NULL
IxBa	NULL
,	NULL
while	NULL
complexed	NULL
IxBa	NULL
is	NULL
quite	NULL
stable	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
relative	NULL
amounts	NULL
of	NULL
free	NULL
versus	NULL
complexed	NULL
IxBa	NULL
,	NULL
we	NULL
examined	NULL
702/3	NULL
and	NULL
Jurkat	NULL
lysates	NULL
from	NULL
which	NULL
all	NULL
c-re/	NULL
and	NULL
p65	NULL
had	NULL
been	NULL
removed	NULL
.	NULL

35S-labeled	NULL
cytoplasmic	NULL
extracts	NULL
were	NULL
exhaustively	NULL
immunoprecipitated	NULL
with	NULL
anti-c-rel	NULL
and	NULL
anti-p65	NULL
,	NULL
and	NULL
the	NULL
amount	NULL
of	NULL
precipitable	NULL
[	NULL
*°S	NULL
]	NULL
IxBa	NULL
in	NULL
the	NULL
supernatant	NULL
was	NULL
compared	NULL
with	NULL
that	NULL
in	NULL
non-depleted	NULL
lysates	NULL
.	NULL

The	NULL
result	NULL
was	NULL
4689	NULL
N.R.Rice	NULL
and	NULL
M.K.Emmst	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Most	NULL
IxBa	NULL
exists	NULL
in	NULL
complexed	NULL
form	NULL
.	NULL

702/3	NULL
or	NULL
Jurkat	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
35S-containing	NULL
medium	NULL
for	NULL
1	NULL
h.	NULL
Cytoplasmic	NULL
extracts	NULL
were	NULL
divided	NULL
in	NULL
half	NULL
.	NULL

One	NULL
half	NULL
was	NULL
treated	NULL
with	NULL
excess	NULL
anti-c-re/	NULL
(	NULL
#	NULL
1050	NULL
,	NULL
m-rel-I	NULL
;	NULL
or	NULL
#	NULL
1135	NULL
,	NULL
h-rel-I	NULL
)	NULL
and	NULL
excess	NULL
anti-p65	NULL
(	NULL
#	NULL
1226	NULL
,	NULL
65-C	NULL
)	NULL
;	NULL
the	NULL
other	NULL
half	NULL
was	NULL
treated	NULL
with	NULL
the	NULL
same	NULL
volume	NULL
of	NULL
an	NULL
irrelevant	NULL
antiserum	NULL
.	NULL

After	NULL
discarding	NULL
the	NULL
precipitates	NULL
,	NULL
the	NULL
supernatants	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-IxBa	NULL
(	NULL
#	NULL
1258	NULL
,	NULL
MAD-3-C	NULL
)	NULL
.	NULL

To	NULL
reduce	NULL
the	NULL
background	NULL
this	NULL
was	NULL
done	NULL
twice	NULL
.	NULL

The	NULL
first	NULL
precipitates	NULL
were	NULL
washed	NULL
,	NULL
boiled	NULL
in	NULL
1	NULL
%	NULL
SDS	NULL
,	NULL
diluted	NULL
and	NULL
reprecipitated	NULL
with	NULL
fresh	NULL
anti-IxBa	NULL
.	NULL

In	NULL
order	NULL
to	NULL
quantify	NULL
the	NULL
amount	NULL
of	NULL
IxBa	NULL
in	NULL
the	NULL
immunodepleted	NULL
extracts	NULL
,	NULL
the	NULL
intensity	NULL
of	NULL
the	NULL
precipitated	NULL
sample	NULL
(	NULL
lane	NULL
5	NULL
for	NULL
702/3	NULL
,	NULL
lane	NULL
13	NULL
for	NULL
Jurkat	NULL
)	NULL
was	NULL
compared	NULL
with	NULL
that	NULL
in	NULL
several	NULL
different	NULL
amounts	NULL
of	NULL
the	NULL
control	NULL
extract	NULL
(	NULL
lanes	NULL
1-4	NULL
)	NULL
for	NULL
702/3	NULL
,	NULL
lanes	NULL
8-11	NULL
for	NULL
Jurkat	NULL
)	NULL
.	NULL

In	NULL
both	NULL
cases	NULL
the	NULL
immunodepleted	NULL
samples	NULL
contained	NULL
IxBax	NULL
at	NULL
only	NULL
~15	NULL
%	NULL
of	NULL
the	NULL
level	NULL
seen	NULL
in	NULL
the	NULL
controls	NULL
.	NULL

Precipitations	NULL
for	NULL
lanes	NULL
6	NULL
and	NULL
12	NULL
were	NULL
performed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
competing	NULL
IxBa	NULL
peptide	NULL
.	NULL

Samples	NULL
in	NULL
lanes	NULL
7	NULL
and	NULL
14	NULL
were	NULL
precipitated	NULL
twice	NULL
with	NULL
anti-p105	NULL
(	NULL
#	NULL
1140	NULL
,	NULL
105-C	NULL
)	NULL
instead	NULL
of	NULL
anti-IxBa	NULL
.	NULL

Since	NULL
a	NULL
strong	NULL
p105	NULL
band	NULL
remains	NULL
in	NULL
the	NULL
immunodepleted	NULL
sample	NULL
(	NULL
lane	NULL
14	NULL
)	NULL
,	NULL
the	NULL
loss	NULL
of	NULL
most	NULL
IxBa	NULL
can	NULL
not	NULL
be	NULL
attributed	NULL
to	NULL
nonspecific	NULL
effects	NULL
of	NULL
incubation	NULL
with	NULL
the	NULL
c-rel	NULL
and	NULL
p65	NULL
antisera	NULL
.	NULL

that	NULL
most	NULL
IxBa	NULL
was	NULL
bound	NULL
to	NULL
c-rel	NULL
or	NULL
p65	NULL
;	NULL
treating	NULL
the	NULL
lysate	NULL
with	NULL
anti-c-rel	NULL
and	NULL
anti-p65	NULL
removed	NULL
about	NULL
85	NULL
%	NULL
of	NULL
the	NULL
total	NULL
IxBa	NULL
(	NULL
Figure	NULL
5	NULL
)	NULL
.	NULL

We	NULL
regard	NULL
this	NULL
as	NULL
a	NULL
minimum	NULL
estimate	NULL
of	NULL
bound	NULL
IxBa	NULL
since	NULL
additional	NULL
molecules	NULL
may	NULL
be	NULL
bound	NULL
to	NULL
p50	NULL
homodimers	NULL
(	NULL
Beg	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Zabel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
,	NULL
which	NULL
were	NULL
not	NULL
removed	NULL
in	NULL
these	NULL
experiments	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
in	NULL
a	NULL
similar	NULL
study	NULL
with	NULL
WEHI	NULL
231	NULL
cells	NULL
,	NULL
the	NULL
small	NULL
amount	NULL
of	NULL
IxBa	NULL
not	NULL
precipitable	NULL
by	NULL
anti-c-re/	NULL
and	NULL
anti-p65	NULL
was	NULL
precipitated	NULL
by	NULL
anti-p50	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
a	NULL
pre-B	NULL
,	NULL
a	NULL
T	NULL
cell	NULL
and	NULL
a	NULL
B	NULL
cell	NULL
line	NULL
,	NULL
almost	NULL
all	NULL
IxBa	NULL
is	NULL
complexed	NULL
rather	NULL
than	NULL
free	NULL
.	NULL

Complexed	NULL
IxBa	NULL
also	NULL
turns	NULL
over	NULL
rapidly	NULL
The	NULL
observation	NULL
that	NULL
most	NULL
IxBa	NULL
is	NULL
bound	NULL
and	NULL
that	NULL
total	NULL
IxBa	NULL
has	NULL
a	NULL
short	NULL
half-life	NULL
necessarily	NULL
implies	NULL
that	NULL
bound	NULL
IxBa	NULL
turns	NULL
over	NULL
rapidly	NULL
.	NULL

To	NULL
test	NULL
this	NULL
prediction	NULL
,	NULL
a	NULL
specific	NULL
subset	NULL
of	NULL
c-rel-containing	NULL
complexes	NULL
was	NULL
examined	NULL
in	NULL
a	NULL
pulse-chase	NULL
experiment	NULL
.	NULL

WEHI	NULL
231	NULL
cells	NULL
were	NULL
labeled	NULL
,	NULL
chased	NULL
for	NULL
various	NULL
times	NULL
and	NULL
immunoprecipitated	NULL
with	NULL
anti-c-rel	NULL
.	NULL

The	NULL
washed	NULL
precipitates	NULL
were	NULL
released	NULL
from	NULL
antibody	NULL
by	NULL
incubation	NULL
in	NULL
excess	NULL
competing	NULL
peptide	NULL
,	NULL
and	NULL
the	NULL
eluted	NULL
(	NULL
c-rel-containing	NULL
)	NULL
material	NULL
was	NULL
reprecipitated	NULL
with	NULL
anti-p65	NULL
and	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

Since	NULL
each	NULL
sample	NULL
was	NULL
precipitated	NULL
sequentially	NULL
with	NULL
anti-c-rel	NULL
and	NULL
anti-p65	NULL
,	NULL
each	NULL
lane	NULL
of	NULL
the	NULL
resulting	NULL
gel	NULL
shows	NULL
complexes	NULL
that	NULL
contain	NULL
both	NULL
c-rel	NULL
and	NULL
p65	NULL
(	NULL
Figure	NULL
6A	NULL
)	NULL
.	NULL

In	NULL
these	NULL
complexes	NULL
both	NULL
[	NULL
*°SJc-rel	NULL
and	NULL
[	NULL
*°S	NULL
]	NULL
p65	NULL
were	NULL
quite	NULL
stable	NULL
over	NULL
the	NULL
course	NULL
of	NULL
22	NULL
h	NULL
,	NULL
suggesting	NULL
that	NULL
they	NULL
associated	NULL
with	NULL
each	NULL
other	NULL
at	NULL
or	NULL
soon	NULL
after	NULL
synthesis	NULL
,	NULL
and	NULL
that	NULL
they	NULL
remained	NULL
associated	NULL
throughout	NULL
the	NULL
experiment	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
**S-labeled	NULL
IxBa	NULL
declined	NULL
4690	NULL
rapidly	NULL
.	NULL

The	NULL
intense	NULL
band	NULL
seen	NULL
in	NULL
the	NULL
pulse-labeled	NULL
sample	NULL
(	NULL
Figure	NULL
6A	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
was	NULL
much	NULL
reduced	NULL
after	NULL
a	NULL
2	NULL
h	NULL
chase	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
and	NULL
was	NULL
almost	NULL
gone	NULL
after	NULL
5	NULL
h	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
association	NULL
between	NULL
newly	NULL
synthesized	NULL
IxBa	NULL
and	NULL
the	NULL
c-rel/p65	NULL
complex	NULL
was	NULL
not	NULL
stable	NULL
,	NULL
for	NULL
the	NULL
disappeared	NULL
with	NULL
a	NULL
short	NULL
half-life	NULL
.	NULL

Next	NULL
we	NULL
tested	NULL
whether	NULL
the	NULL
displaced	NULL
[	NULL
*°S	NULL
]	NULL
lxBa	NULL
is	NULL
replaced	NULL
with	NULL
new	NULL
IxBa	NULL
molecules	NULL
.	NULL

As	NULL
in	NULL
the	NULL
preceding	NULL
experiment	NULL
,	NULL
c-re/-containing	NULL
complexes	NULL
were	NULL
collected	NULL
at	NULL
each	NULL
time	NULL
point	NULL
.	NULL

These	NULL
were	NULL
reprecipitated	NULL
with	NULL
anti-IxBa	NULL
and	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
gel	NULL
shows	NULL
only	NULL
those	NULL
complexes	NULL
that	NULL
contained	NULL
both	NULL
c-re/l	NULL
and	NULL
IxBa	NULL
(	NULL
Figure	NULL
6B	NULL
)	NULL
.	NULL

As	NULL
in	NULL
Figure	NULL
6A	NULL
,	NULL
pulse-labeled	NULL
was	NULL
stable	NULL
,	NULL
while	NULL
[	NULL
*°S	NULL
]	NULL
IxBa	NULL
declined	NULL
rapidly	NULL
.	NULL

However	NULL
,	NULL
the	NULL
fact	NULL
that	NULL
anti-IxBa	NULL
precipitated	NULL
c-rel	NULL
even	NULL
after	NULL
[	NULL
°°S	NULL
]	NULL
IxBa	NULL
had	NULL
almost	NULL
disappeared	NULL
(	NULL
Figure	NULL
6B	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
shows	NULL
that	NULL
new	NULL
unlabeled	NULL
IxBa	NULL
replaced	NULL
the	NULL
lost	NULL
labeled	NULL
molecules	NULL
.	NULL

This	NULL
conclusion	NULL
was	NULL
confirmed	NULL
by	NULL
chasing	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
cycloheximide	NULL
(	NULL
Figure	NULL
6C	NULL
)	NULL
.	NULL

The	NULL
result	NULL
was	NULL
that	NULL
after	NULL
a	NULL
90	NULL
min	NULL
chase	NULL
anti-IxBa	NULL
was	NULL
unable	NULL
to	NULL
precipitate	NULL
[	NULL
*°S	NULL
)	NULL
re/-containing	NULL
complexes	NULL
(	NULL
compare	NULL
the	NULL
c-re/	NULL
band	NULL
in	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
complexed	NULL
IxBa	NULL
is	NULL
unstable	NULL
.	NULL

Even	NULL
in	NULL
unstimulated	NULL
B	NULL
cells	NULL
it	NULL
is	NULL
frequently	NULL
lost	NULL
from	NULL
c-re/-	NULL
and	NULL
p65-containing	NULL
complexes	NULL
and	NULL
is	NULL
replaced	NULL
by	NULL
a	NULL
newer	NULL
molecule	NULL
.	NULL

There	NULL
are	NULL
two	NULL
further	NULL
predictions	NULL
.	NULL

First	NULL
,	NULL
in	NULL
c-re/-IxBa	NULL
complexes	NULL
,	NULL
the	NULL
incorporation	NULL
of	NULL
°°S	NULL
by	NULL
IxBa	NULL
and	NULL
that	NULL
by	NULL
c-rel	NULL
should	NULL
reflect	NULL
not	NULL
only	NULL
their	NULL
contents	NULL
of	NULL
methionine	NULL
plus	NULL
cysteine	NULL
but	NULL
also	NULL
their	NULL
differing	NULL
half-lives	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
the	NULL
intensity	NULL
of	NULL
the	NULL
IxBa	NULL
band	NULL
in	NULL
Figure	NULL
6B	NULL
,	NULL
lane	NULL
1	NULL
,	NULL
is	NULL
significantly	NULL
greater	NULL
than	NULL
that	NULL
of	NULL
c-re/	NULL
.	NULL

The	NULL
labeling	NULL
period	NULL
in	NULL
that	NULL
experiment	NULL
was	NULL
1	NULL
h	NULL
(	NULL
which	NULL
is	NULL
two	NULL
half-lives	NULL
of	NULL
IxBa	NULL
)	NULL
,	NULL
so	NULL
substantial	NULL
turnover	NULL
of	NULL
newly	NULL
synthesized	NULL
molecules	NULL
occurred	NULL
during	NULL
that	NULL
time	NULL
.	NULL

When	NULL
cells	NULL
were	NULL
labeled	NULL
for	NULL
only	NULL
10	NULL
min	NULL
,	NULL
the	NULL
difference	NULL
in	NULL
incorporation	NULL
between	NULL
IxBa	NULL
and	NULL
c-rel	NULL
was	NULL
greatly	NULL
magnified	NULL
(	NULL
to	NULL
at	NULL
least	NULL
a	NULL
factor	NULL
of	NULL
5	NULL
)	NULL
,	NULL
as	NULL
expected	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Second	NULL
,	NULL
treatment	NULL
with	NULL
a	NULL
protein	NULL
synthesis	NULL
inhibitor	NULL
would	NULL
be	NULL
expected	NULL
to	NULL
increase	NULL
nuclear	NULL
c-re/	NULL
and	NULL
p65	NULL
,	NULL
as	NULL
old	NULL
IxBa	NULL
decays	NULL
but	NULL
synthesis	NULL
of	NULL
new	NULL
IxBa	NULL
is	NULL
blocked	NULL
.	NULL

To	NULL
test	NULL
this	NULL
,	NULL
WEHI	NULL
231	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
cycloheximide	NULL
for	NULL
varying	NULL
times	NULL
,	NULL
and	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
extracts	NULL
were	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
(	NULL
Figure	NULL
6D	NULL
)	NULL
.	NULL

The	NULL
results	NULL
showed	NULL
relatively	NULL
little	NULL
nuclear	NULL
c-re/	NULL
or	NULL
p65	NULL
after	NULL
15	NULL
or	NULL
50	NULL
min	NULL
of	NULL
treatment	NULL
,	NULL
but	NULL
a	NULL
significantly	NULL
increased	NULL
level	NULL
after	NULL
3	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
cycloheximide	NULL
.	NULL

There	NULL
is	NULL
a	NULL
substantial	NULL
amount	NULL
of	NULL
nuclear	NULL
p50	NULL
in	NULL
untreated	NULL
cells	NULL
,	NULL
and	NULL
this	NULL
level	NULL
also	NULL
increased	NULL
somewhat	NULL
after	NULL
3	NULL
h	NULL
treatment	NULL
.	NULL

(	NULL
We	NULL
have	NULL
observed	NULL
repeatedly	NULL
that	NULL
cycloheximide	NULL
at	NULL
20	NULL
ug/ml	NULL
does	NULL
not	NULL
inhibit	NULL
protein	NULL
synthesis	NULL
completely	NULL
;	NULL
this	NULL
may	NULL
account	NULL
for	NULL
the	NULL
lack	NULL
of	NULL
response	NULL
after	NULL
50	NULL
min	NULL
treatment	NULL
.	NULL
)	NULL

Thus	NULL
,	NULL
cycloheximide	NULL
blocks	NULL
synthesis	NULL
of	NULL
most	NULL
IxBa	NULL
(	NULL
Figures	NULL
2A	NULL
and	NULL
B	NULL
and	NULL
6C	NULL
)	NULL
and	NULL
results	NULL
in	NULL
increased	NULL
levels	NULL
of	NULL
nuclear	NULL
c-re/	NULL
,	NULL
p65	NULL
and	NULL
p50	NULL
.	NULL

This	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
model	NULL
of	NULL
unstable	NULL
association	NULL
of	NULL
IxBa	NULL
with	NULL
rel	NULL
family	NULL
complexes	NULL
.	NULL

The	NULL
rapid	NULL
turnover	NULL
of	NULL
bound	NULL
IxBa	NULL
is	NULL
not	NULL
unique	NULL
to	NULL
B	NULL
cells	NULL
.	NULL

In	NULL
a	NULL
pulse-chase	NULL
experiment	NULL
with	NULL
7027/3	NULL
pre-B	NULL
cells	NULL
we	NULL
examined	NULL
complexes	NULL
containing	NULL
IxBa	NULL
and	NULL
c-re/	NULL
or	NULL
p65	NULL
.	NULL

The	NULL
result	NULL
was	NULL
qualitatively	NULL
the	NULL
same	NULL
as	NULL
that	NULL
with	NULL
B	NULL
cells	NULL
.	NULL

A	NULL
constant	NULL
level	NULL
of	NULL
*5S-labeled	NULL
c-re/	NULL
or	NULL
p65	NULL
was	NULL
associated	NULL
with	NULL
IxBa	NULL
,	NULL
but	NULL
[	NULL
°°S	NULL
}	NULL
lxBa	NULL
declined	NULL
with	NULL
a	NULL
half-life	NULL
of	NULL
~1	NULL
h	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
even	NULL
in	NULL
non-B	NULL
cells	NULL
IxBa	NULL
complexes	NULL
are	NULL
dynamic	NULL
.	NULL

Newly	NULL
synthesized	NULL
IxBa	NULL
remains	NULL
associated	NULL
with	NULL
rel	NULL
or	NULL
p65	NULL
for	NULL
a	NULL
relatively	NULL
short	NULL
time	NULL
,	NULL
is	NULL
lost	NULL
and	NULL
is	NULL
0	NULL
18	NULL
t	NULL
T	NULL
Ant	NULL
Instability	NULL
of	NULL
IxBa	NULL
complexes	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Complexed	NULL
IxBa	NULL
turns	NULL
over	NULL
rapidly	NULL
.	NULL

(	NULL
A	NULL
)	NULL
WEHI	NULL
231	NULL
cells	NULL
were	NULL
labeled	NULL
and	NULL
chased	NULL
as	NULL
detailed	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Figure	NULL
5	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
in	NULL
TNT	NULL
buffer	NULL
,	NULL
and	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-c-re/	NULL
(	NULL
#	NULL
1051	NULL
,	NULL
m-rel-I	NULL
)	NULL
.	NULL

Precipitates	NULL
were	NULL
washed	NULL
and	NULL
then	NULL
released	NULL
from	NULL
antibody	NULL
by	NULL
incubation	NULL
with	NULL
excess	NULL
competing	NULL
peptide	NULL
1051	NULL
.	NULL

Eluates	NULL
were	NULL
reprecipitated	NULL
with	NULL
anti-p65	NULL
(	NULL
#	NULL
1226	NULL
,	NULL
65-C	NULL
)	NULL
and	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

(	NULL
B	NULL
)	NULL
WEHI	NULL
231	NULL
cells	NULL
were	NULL
labeled	NULL
and	NULL
chased	NULL
,	NULL
and	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
and	NULL
eluted	NULL
with	NULL
anti-c-re/	NULL
and	NULL
peptide	NULL
1051	NULL
,	NULL
respectively	NULL
,	NULL
as	NULL
in	NULL
(	NULL
A	NULL
)	NULL
.	NULL

Eluates	NULL
were	NULL
reprecipitated	NULL
with	NULL
anti-IxBa	NULL
(	NULL
#	NULL
1258	NULL
,	NULL
MAD-3C	NULL
)	NULL
and	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

(	NULL
C	NULL
)	NULL
WEHI	NULL
231	NULL
cells	NULL
were	NULL
3°S-labeled	NULL
and	NULL
chased	NULL
for	NULL
90	NULL
min	NULL
with	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
or	NULL
without	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
cycloheximide	NULL
at	NULL
20	NULL
pg/ml	NULL
.	NULL

Lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-c-re/	NULL
(	NULL
#	NULL
1050	NULL
,	NULL
m-re/-1	NULL
)	NULL
,	NULL
eluted	NULL
with	NULL
peptide	NULL
1050	NULL
,	NULL
and	NULL
reprecipitated	NULL
with	NULL
anti-IxBa	NULL
(	NULL
#	NULL
1258	NULL
,	NULL
MAD-3C	NULL
)	NULL
.	NULL

In	NULL
parts	NULL
A	NULL
,	NULL
B	NULL
and	NULL
C	NULL
,	NULL
each	NULL
lane	NULL
contains	NULL
precipitate	NULL
from	NULL
~10	NULL
``	NULL
cells	NULL
and	NULL
the	NULL
films	NULL
were	NULL
exposed	NULL
for	NULL
3-5	NULL
days	NULL
.	NULL

(	NULL
D	NULL
)	NULL
WEHI	NULL
231	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
complete	NULL
medium	NULL
plus	NULL
cycloheximide	NULL
(	NULL
20	NULL
pg/ml	NULL
!	NULL
)	NULL

for	NULL
15	NULL
min	NULL
,	NULL
50	NULL
min	NULL
or	NULL
3	NULL
h.	NULL
For	NULL
each	NULL
time	NULL
,	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
extracts	NULL
were	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
with	NULL
anti-c-rel	NULL
(	NULL
#	NULL
1158	NULL
,	NULL
re/-D	NULL
,	NULL
anti-p65	NULL
(	NULL
#	NULL
1226	NULL
,	NULL
65-C	NULL
)	NULL
or	NULL
anti-p50	NULL
(	NULL
#	NULL
1157	NULL
,	NULL
105-1	NULL
)	NULL
.	NULL

Each	NULL
lane	NULL
contains	NULL
extract	NULL
from	NULL
~5	NULL
x	NULL
105	NULL
cells	NULL
.	NULL

replaced	NULL
by	NULL
a	NULL
newer	NULL
molecule	NULL
.	NULL

Since	NULL
the	NULL
decay	NULL
rate	NULL
mirrors	NULL
the	NULL
turnover	NULL
rate	NULL
of	NULL
total	NULL
IxBa	NULL
,	NULL
the	NULL
lost	NULL
molecule	NULL
is	NULL
most	NULL
likely	NULL
degraded	NULL
.	NULL

IxBa	NULL
turnover	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
LPS	NULL
The	NULL
preceding	NULL
experiments	NULL
have	NULL
shown	NULL
that	NULL
in	NULL
unstimulated	NULL
cells	NULL
nearly	NULL
all	NULL
IxBa	NULL
is	NULL
complexed	NULL
with	NULL
rel	NULL
family	NULL
members	NULL
and	NULL
that	NULL
it	NULL
turns	NULL
over	NULL
rapidly	NULL
(	NULL
half-life	NULL
30-60	NULL
min	NULL
)	NULL
.	NULL

They	NULL
also	NULL
demonstrated	NULL
that	NULL
treatment	NULL
with	NULL
an	NULL
activating	NULL
agent	NULL
accelerates	NULL
this	NULL
normal	NULL
process	NULL
:	NULL
all	NULL
pre-existing	NULL
IxBa	NULL
disappeared	NULL
from	NULL
rel-containing	NULL
complexes	NULL
by	NULL
90	NULL
min	NULL
after	NULL
addition	NULL
of	NULL
LPS	NULL
.	NULL

These	NULL
findings	NULL
predict	NULL
that	NULL
the	NULL
turnover	NULL
time	NULL
of	NULL
IxBa	NULL
should	NULL
be	NULL
reduced	NULL
in	NULL
LPS-treated	NULL
cells	NULL
.	NULL

To	NULL
test	NULL
this	NULL
,	NULL
702/3	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
3	NULL
h	NULL
with	NULL
or	NULL
without	NULL
LPS	NULL
,	NULL
then	NULL
for	NULL
45	NULL
min	NULL
and	NULL
chased	NULL
in	NULL
non-radioactive	NULL
medium	NULL
for	NULL
varying	NULL
times	NULL
.	NULL

(	NULL
The	NULL
LPS-treated	NULL
cells	NULL
also	NULL
received	NULL
LPS	NULL
during	NULL
the	NULL
labeling	NULL
and	NULL
chase	NULL
periods	NULL
.	NULL
)	NULL

c-rel-	NULL
and	NULL
p6S-containing	NULL
complexes	NULL
were	NULL
precipitated	NULL
,	NULL
eluted	NULL
with	NULL
peptides	NULL
and	NULL
reprecipitated	NULL
with	NULL
anti-IxBa	NULL
.	NULL

The	NULL
resulting	NULL
gel	NULL
therefore	NULL
shows	NULL
only	NULL
those	NULL
complexes	NULL
containing	NULL
IxBa	NULL
and	NULL
c-re/	NULL
and/or	NULL
p65	NULL
(	NULL
Figure	NULL
7	NULL
)	NULL
.	NULL

The	NULL
result	NULL
was	NULL
a	NULL
noticeable	NULL
decrease	NULL
in	NULL
the	NULL
turnover	NULL
time	NULL
of	NULL
bound	NULL
[	NULL
3°S	NULL
]	NULL
IlxBa	NULL
in	NULL
LPS-treated	NULL
cells	NULL
.	NULL

Its	NULL
half-life	NULL
in	NULL
untreated	NULL
cells	NULL
was	NULL
~1	NULL
h	NULL
(	NULL
lanes	NULL
1-4	NULL
)	NULL
,	NULL
but	NULL
it	NULL
was	NULL
considerably	NULL
less	NULL
than	NULL
that	NULL
in	NULL
LPS-treated	NULL
cells	NULL
(	NULL
lanes	NULL
5-8	NULL
)	NULL
.	NULL

Examining	NULL
total	NULL
rather	NULL
than	NULL
bound	NULL
IxBa	NULL
gave	NULL
the	NULL
same	NULL
result	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
half-life	NULL
of	NULL
IxBa	NULL
,	NULL
already	NULL
short	NULL
in	NULL
4691	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

Turnover	NULL
of	NULL
IxBa	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
LPS	NULL
.	NULL

702/3	NULL
cells	NULL
were	NULL
grown	NULL
with	NULL
or	NULL
without	NULL
LPS	NULL
(	NULL
15	NULL
pg/ml	NULL
)	NULL
for	NULL
3	NULL
h	NULL
,	NULL
labeled	NULL
in	NULL
medium	NULL
containing	NULL
and	NULL
[	NULL
3°S	NULL
]	NULL
cysteine	NULL
(	NULL
100	NULL
gCi/ml	NULL
each	NULL
)	NULL
for	NULL
45	NULL
min	NULL
and	NULL
then	NULL
chased	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Figure	NULL
4B	NULL
.	NULL

The	NULL
LPS-treated	NULL
cells	NULL
also	NULL
received	NULL
LPS	NULL
during	NULL
the	NULL
labeling	NULL
and	NULL
chase	NULL
periods	NULL
.	NULL

Cytoplasmic	NULL
extracts	NULL
were	NULL
precipitated	NULL
with	NULL
combined	NULL
anti-c-rel	NULL
(	NULL
#	NULL
1051	NULL
,	NULL
m-rel-I	NULL
)	NULL
and	NULL
anti-p65	NULL
(	NULL
#	NULL
1226	NULL
,	NULL
65-C	NULL
)	NULL
.	NULL

Precipitates	NULL
were	NULL
eluted	NULL
with	NULL
peptides	NULL
1051	NULL
and	NULL
1226	NULL
,	NULL
and	NULL
eluates	NULL
were	NULL
reprecipitated	NULL
with	NULL
anti-IxBa	NULL
(	NULL
#	NULL
1258	NULL
,	NULL
MAD-3-C	NULL
)	NULL
and	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

Each	NULL
lane	NULL
contains	NULL
the	NULL
precipitate	NULL
from	NULL
~2	NULL
x	NULL
10	NULL
``	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
film	NULL
was	NULL
exposed	NULL
for	NULL
3	NULL
weeks	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
the	NULL
80	NULL
kDa	NULL
band	NULL
is	NULL
unknown	NULL
;	NULL
the	NULL
protein	NULL
at	NULL
45	NULL
kDa	NULL
is	NULL
most	NULL
likely	NULL
p50	NULL
.	NULL

unstimulated	NULL
cells	NULL
,	NULL
is	NULL
decreased	NULL
even	NULL
further	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
activating	NULL
agent	NULL
.	NULL

Stability	NULL
of	NULL
IxBa	NULL
in	NULL
transfected	NULL
cells	NULL
Two	NULL
recent	NULL
papers	NULL
examined	NULL
the	NULL
stability	NULL
of	NULL
IxBa	NULL
in	NULL
cells	NULL
transfected	NULL
with	NULL
expression	NULL
vectors	NULL
encoding	NULL
IxBa	NULL
and/or	NULL
p65	NULL
(	NULL
Scott	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Sun	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

When	NULL
transfected	NULL
alone	NULL
,	NULL
the	NULL
half-life	NULL
of	NULL
IxBa	NULL
was	NULL
found	NULL
to	NULL
be	NULL
30-40	NULL
min	NULL
.	NULL

However	NULL
,	NULL
when	NULL
cotransfected	NULL
with	NULL
p65	NULL
,	NULL
or	NULL
when	NULL
induced	NULL
by	NULL
overexpression	NULL
of	NULL
p65	NULL
,	NULL
IxBa	NULL
was	NULL
very	NULL
stable	NULL
,	NULL
with	NULL
a	NULL
half-life	NULL
of	NULL
many	NULL
hours	NULL
.	NULL

These	NULL
results	NULL
led	NULL
to	NULL
the	NULL
conclusion	NULL
that	NULL
while	NULL
free	NULL
IxBa	NULL
turns	NULL
over	NULL
rapidly	NULL
,	NULL
bound	NULL
IxBa	NULL
does	NULL
not	NULL
.	NULL

Yet	NULL
our	NULL
experiments	NULL
reported	NULL
above	NULL
showed	NULL
that	NULL
complexed	NULL
IxBa	NULL
is	NULL
unstable	NULL
.	NULL

We	NULL
have	NULL
therefore	NULL
tested	NULL
whether	NULL
this	NULL
difference	NULL
is	NULL
attributable	NULL
to	NULL
experimental	NULL
methodology	NULL
or	NULL
to	NULL
the	NULL
use	NULL
of	NULL
transfected	NULL
versus	NULL
non-transfected	NULL
cells	NULL
.	NULL

We	NULL
transfected	NULL
cells	NULL
with	NULL
IxBa	NULL
DNA	NULL
with	NULL
or	NULL
without	NULL
p65	NULL
DNA	NULL
,	NULL
and	NULL
we	NULL
examined	NULL
the	NULL
stability	NULL
of	NULL
IxBa	NULL
protein	NULL
using	NULL
the	NULL
two-step	NULL
immunoprecipitation	NULL
protocols	NULL
detailed	NULL
above	NULL
.	NULL

The	NULL
results	NULL
are	NULL
in	NULL
complete	NULL
agreement	NULL
with	NULL
those	NULL
of	NULL
Sun	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
and	NULL
Scott	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

In	NULL
a	NULL
pulse-chase	NULL
experiment	NULL
,	NULL
transfected	NULL
IxBa	NULL
had	NULL
a	NULL
half-life	NULL
of	NULL
less	NULL
than	NULL
1	NULL
h	NULL
and	NULL
was	NULL
only	NULL
barely	NULL
detectable	NULL
after	NULL
2	NULL
h	NULL
(	NULL
Figure	NULL
8	NULL
,	NULL
top	NULL
panel	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
IxBa	NULL
was	NULL
much	NULL
more	NULL
stable	NULL
when	NULL
cotransfected	NULL
with	NULL
p65	NULL
.	NULL

This	NULL
was	NULL
true	NULL
regardless	NULL
of	NULL
whether	NULL
immunoprecipitation	NULL
was	NULL
performed	NULL
with	NULL
anti-IxBa	NULL
alone	NULL
(	NULL
Figure	NULL
8	NULL
,	NULL
panel	NULL
a	NULL
)	NULL
,	NULL
or	NULL
with	NULL
sequential	NULL
anti-IxBa	NULL
and	NULL
anti-p65	NULL
(	NULL
panel	NULL
b	NULL
)	NULL
.	NULL

In	NULL
a	NULL
separate	NULL
experiment	NULL
we	NULL
examined	NULL
the	NULL
stability	NULL
of	NULL
IxBa	NULL
induced	NULL
by	NULL
overexpression	NULL
of	NULL
transfected	NULL
p65	NULL
.	NULL

Just	NULL
as	NULL
shown	NULL
by	NULL
Scott	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
,	NULL
the	NULL
induced	NULL
IxBa	NULL
was	NULL
very	NULL
stable	NULL
,	NULL
with	NULL
no	NULL
detectable	NULL
decrease	NULL
after	NULL
a	NULL
7	NULL
h	NULL
chase	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
there	NULL
is	NULL
a	NULL
real	NULL
difference	NULL
in	NULL
the	NULL
stability	NULL
of	NULL
IxBa	NULL
in	NULL
transfected	NULL
versus	NULL
non-transfected	NULL
cells	NULL
,	NULL
4692	NULL
Fig	NULL
.	NULL

8	NULL
.	NULL

Stability	NULL
of	NULL
IxBa	NULL
in	NULL
transfected	NULL
cells	NULL
.	NULL

Human	NULL
293	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
an	NULL
expression	NULL
vector	NULL
encoding	NULL
IxBa	NULL
(	NULL
Haskill	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
with	NULL
or	NULL
without	NULL
a	NULL
second	NULL
expression	NULL
vector	NULL
encoding	NULL
p65	NULL
(	NULL
Ruben	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992b	NULL
)	NULL
.	NULL

48	NULL
h	NULL
later	NULL
,	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
medium	NULL
containing	NULL
[	NULL
35SJmethionine	NULL
for	NULL
1	NULL
h	NULL
and	NULL
then	NULL
chased	NULL
in	NULL
non-radioactive	NULL
medium	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

Top	NULL
panel	NULL
:	NULL
cytoplasmic	NULL
extracts	NULL
from	NULL
cells	NULL
transfected	NULL
with	NULL
IxBa	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-lxBa	NULL
(	NULL
#	NULL
1258	NULL
,	NULL
MAD-3-C	NULL
)	NULL
.	NULL

Precipitates	NULL
were	NULL
boiled	NULL
and	NULL
reprecipitated	NULL
with	NULL
fresh	NULL
serum	NULL
,	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Figure	NULL
4B	NULL
.	NULL

Middle	NULL
panel	NULL
:	NULL
cytoplasmic	NULL
extracts	NULL
from	NULL
cells	NULL
cotransfected	NULL
with	NULL
IxBa	NULL
and	NULL
p65	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-IxBa	NULL
,	NULL
boiled	NULL
and	NULL
then	NULL
reprecipitated	NULL
with	NULL
fresh	NULL
anti-IxBa	NULL
,	NULL
as	NULL
above	NULL
.	NULL

Bottom	NULL
panel	NULL
:	NULL
cytoplasmic	NULL
extracts	NULL
from	NULL
cotransfected	NULL
cells	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-IxBa	NULL
.	NULL

The	NULL
precipitate	NULL
was	NULL
eluted	NULL
from	NULL
antibody	NULL
with	NULL
excess	NULL
peptide	NULL
,	NULL
and	NULL
the	NULL
eluted	NULL
material	NULL
was	NULL
precipitated	NULL
with	NULL
anti-p65	NULL
(	NULL
#	NULL
1226	NULL
,	NULL
65-C	NULL
)	NULL
.	NULL

Precipitates	NULL
were	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

Only	NULL
the	NULL
portion	NULL
of	NULL
the	NULL
gel	NULL
containing	NULL
IxBa	NULL
is	NULL
shown	NULL
.	NULL

presumably	NULL
resulting	NULL
from	NULL
the	NULL
sustained	NULL
high	NULL
level	NULL
expression	NULL
in	NULL
the	NULL
former	NULL
.	NULL

Discussion	NULL
We	NULL
report	NULL
here	NULL
on	NULL
two	NULL
key	NULL
features	NULL
of	NULL
IxBa	NULL
regulation	NULL
of	NULL
NF-xB	NULL
in	NULL
the	NULL
unstimulated	NULL
cell	NULL
.	NULL

First	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
essentially	NULL
all	NULL
IxBa	NULL
is	NULL
complexed	NULL
to	NULL
rel	NULL
family	NULL
members	NULL
in	NULL
the	NULL
cytoplasm	NULL
:	NULL
there	NULL
is	NULL
little	NULL
or	NULL
no	NULL
free	NULL
IxBa	NULL
.	NULL

Second	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
c-rel	NULL
or	NULL
p65	NULL
,	NULL
IxBa	NULL
is	NULL
unstable	NULL
,	NULL
turning	NULL
over	NULL
with	NULL
a	NULL
half-life	NULL
of	NULL
~30	NULL
min	NULL
(	NULL
WEHI	NULL
231	NULL
B	NULL
cells	NULL
)	NULL
to	NULL
60	NULL
min	NULL
(	NULL
various	NULL
non-B	NULL
cell	NULL
lines	NULL
)	NULL
.	NULL

This	NULL
implied	NULL
that	NULL
complexes	NULL
themselves	NULL
are	NULL
unstable	NULL
,	NULL
with	NULL
frequent	NULL
dissociation	NULL
and/or	NULL
degradation	NULL
of	NULL
the	NULL
IxBa-and	NULL
we	NULL
were	NULL
able	NULL
to	NULL
demonstrate	NULL
this	NULL
directly	NULL
.	NULL

Synthesis	NULL
of	NULL
new	NULL
IxBa	NULL
is	NULL
rapid	NULL
enough	NULL
that	NULL
most	NULL
liberated	NULL
rel	NULL
family	NULL
dimers	NULL
are	NULL
efficiently	NULL
captured	NULL
by	NULL
new	NULL
IxBa	NULL
and	NULL
retained	NULL
in	NULL
the	NULL
cytoplasm	NULL
.	NULL

The	NULL
experiments	NULL
reported	NULL
here	NULL
also	NULL
reveal	NULL
aspects	NULL
of	NULL
IxBa	NULL
regulation	NULL
in	NULL
the	NULL
activated	NULL
cell	NULL
.	NULL

First	NULL
,	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
,	NULL
all	NULL
previously	NULL
synthesized	NULL
IxBa	NULL
was	NULL
gradually	NULL
lost	NULL
from	NULL
rel-and	NULL
p65-containing	NULL
complexes	NULL
in	NULL
both	NULL
WEHI	NULL
231	NULL
and	NULL
702/3	NULL
cells	NULL
.	NULL

Since	NULL
the	NULL
lost	NULL
IxBa	NULL
was	NULL
not	NULL
detectable	NULL
by	NULL
immunoprecipitation	NULL
,	NULL
it	NULL
was	NULL
probably	NULL
rapidly	NULL
degraded	NULL
.	NULL

Dissociation	NULL
of	NULL
complexes	NULL
was	NULL
correlated	NULL
with	NULL
the	NULL
appearance	NULL
of	NULL
rel	NULL
family	NULL
members	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

These	NULL
results	NULL
complement	NULL
those	NULL
from	NULL
recent	NULL
experiments	NULL
using	NULL
TNFa	NULL
,	NULL
where	NULL
treatment	NULL
resulted	NULL
in	NULL
maximal	NULL
nuclear	NULL
xB-binding	NULL
activity	NULL
after	NULL
only	NULL
a	NULL
few	NULL
minutes	NULL
.	NULL

The	NULL
level	NULL
of	NULL
total	NULL
cellular	NULL
IxBa	NULL
was	NULL
monitored	NULL
by	NULL
immunoblotting	NULL
and	NULL
was	NULL
found	NULL
to	NULL
decline	NULL
drastically	NULL
almost	NULL
immediately	NULL
,	NULL
correlating	NULL
nicely	NULL
with	NULL
the	NULL
rapid	NULL
rise	NULL
in	NULL
DNA-binding	NULL
activity	NULL
(	NULL
Brown	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Sun	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

While	NULL
this	NULL
manuscript	NULL
was	NULL
being	NULL
reviewed	NULL
,	NULL
two	NULL
additional	NULL
studies	NULL
documented	NULL
the	NULL
loss	NULL
of	NULL
IxBa	NULL
following	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
various	NULL
activating	NULL
agents	NULL
,	NULL
including	NULL
LPS	NULL
(	NULL
Beg	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Cordle	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Second	NULL
,	NULL
during	NULL
the	NULL
relatively	NULL
slow	NULL
LPS-induced	NULL
process	NULL
,	NULL
some	NULL
of	NULL
the	NULL
lost	NULL
IxBa	NULL
molecules	NULL
were	NULL
replaced	NULL
with	NULL
newly	NULL
synthesized	NULL
ones	NULL
:	NULL
even	NULL
after	NULL
90	NULL
min	NULL
of	NULL
treatment	NULL
,	NULL
anti-IxBa	NULL
still	NULL
precipitated	NULL
some	NULL
previously	NULL
synthesized	NULL
c-re/	NULL
and	NULL
p65	NULL
,	NULL
even	NULL
though	NULL
all	NULL
of	NULL
the	NULL
old	NULL
IxBa	NULL
had	NULL
disappeared	NULL
.	NULL

Thus	NULL
even	NULL
during	NULL
stimulation	NULL
of	NULL
the	NULL
cell	NULL
,	NULL
not	NULL
every	NULL
dissociation	NULL
event	NULL
results	NULL
in	NULL
nuclear	NULL
translocation	NULL
.	NULL

Rather	NULL
,	NULL
the	NULL
high	NULL
rate	NULL
of	NULL
IxBa	NULL
synthesis	NULL
results	NULL
in	NULL
modulation	NULL
of	NULL
the	NULL
response	NULL
to	NULL
LPS	NULL
and	NULL
prevents	NULL
an	NULL
all-out	NULL
migration	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

These	NULL
competing	NULL
processes	NULL
of	NULL
association	NULL
and	NULL
dissociation	NULL
may	NULL
be	NULL
detectable	NULL
only	NULL
with	NULL
a	NULL
relatively	NULL
weak	NULL
activator	NULL
such	NULL
as	NULL
LPS	NULL
.	NULL

With	NULL
a	NULL
strong	NULL
signal	NULL
such	NULL
as	NULL
TNFa	NULL
(	NULL
Hohmann	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
,	NULL
the	NULL
speed	NULL
and	NULL
extent	NULL
of	NULL
the	NULL
reaction	NULL
may	NULL
preclude	NULL
their	NULL
observation	NULL
,	NULL
at	NULL
least	NULL
initially	NULL
.	NULL

Third	NULL
,	NULL
the	NULL
fact	NULL
that	NULL
some	NULL
liberated	NULL
dimers	NULL
were	NULL
able	NULL
to	NULL
associate	NULL
with	NULL
newly	NULL
synthesized	NULL
IxBa	NULL
strongly	NULL
suggests	NULL
that	NULL
the	NULL
LPS-induced	NULL
signal	NULL
causes	NULL
disruption	NULL
of	NULL
complexes	NULL
rather	NULL
than	NULL
preventing	NULL
their	NULL
association	NULL
,	NULL
and	NULL
that	NULL
complexes	NULL
are	NULL
broken	NULL
due	NULL
to	NULL
modification	NULL
of	NULL
IxBa	NULL
,	NULL
and	NULL
not	NULL
of	NULL
the	NULL
dimers	NULL
.	NULL

We	NULL
wish	NULL
now	NULL
to	NULL
consider	NULL
the	NULL
unstimulated	NULL
cell	NULL
in	NULL
more	NULL
detail	NULL
.	NULL

First	NULL
,	NULL
why	NULL
is	NULL
there	NULL
little	NULL
or	NULL
no	NULL
free	NULL
IxBa	NULL
in	NULL
the	NULL
unstimulated	NULL
cell	NULL
?	NULL

Excess	NULL
inhibitor	NULL
could	NULL
interfere	NULL
with	NULL
response	NULL
to	NULL
an	NULL
activating	NULL
signal	NULL
,	NULL
so	NULL
the	NULL
advantage	NULL
of	NULL
this	NULL
arrangement	NULL
is	NULL
evident	NULL
.	NULL

But	NULL
how	NULL
is	NULL
the	NULL
precise	NULL
balance	NULL
between	NULL
NF-xB	NULL
and	NULL
IxBa	NULL
maintained	NULL
?	NULL

Roughly	NULL
coordinated	NULL
rates	NULL
of	NULL
synthesis	NULL
are	NULL
probably	NULL
involved	NULL
,	NULL
but	NULL
it	NULL
is	NULL
also	NULL
possible	NULL
that	NULL
free	NULL
IxBa	NULL
(	NULL
i.e	NULL
.	NULL

never	NULL
complexed	NULL
,	NULL
as	NULL
distinguished	NULL
from	NULL
dissociated	NULL
)	NULL
is	NULL
more	NULL
unstable	NULL
than	NULL
complexed	NULL
IxBax	NULL
,	NULL
just	NULL
as	NULL
indicated	NULL
by	NULL
the	NULL
transfection	NULL
experiments	NULL
(	NULL
Figure	NULL
8	NULL
;	NULL
Scott	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Sun	NULL
etal	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

It	NULL
is	NULL
not	NULL
clear	NULL
why	NULL
cotransfected	NULL
IxBa	NULL
is	NULL
so	NULL
stable	NULL
relative	NULL
to	NULL
the	NULL
endogenous	NULL
IxBa	NULL
in	NULL
the	NULL
various	NULL
cell	NULL
lines	NULL
we	NULL
examined	NULL
.	NULL

However	NULL
,	NULL
if	NULL
the	NULL
transfected	NULL
cells	NULL
accurately	NULL
reflect	NULL
the	NULL
normal	NULL
ratio	NULL
of	NULL
the	NULL
half-lives	NULL
of	NULL
complexed	NULL
versus	NULL
free	NULL
IxBax	NULL
,	NULL
then	NULL
free	NULL
IxBa	NULL
in	NULL
non-transfected	NULL
cells	NULL
may	NULL
survive	NULL
for	NULL
only	NULL
a	NULL
few	NULL
minutes	NULL
at	NULL
most	NULL
.	NULL

Why	NULL
is	NULL
complexed	NULL
IxBa	NULL
unstable	NULL
?	NULL

(	NULL
i	NULL
)	NULL
Perhaps	NULL
the	NULL
association	NULL
between	NULL
rel	NULL
family	NULL
members	NULL
and	NULL
IxBa	NULL
is	NULL
not	NULL
strong	NULL
.	NULL

In	NULL
that	NULL
case	NULL
occasional	NULL
dissociation	NULL
events	NULL
might	NULL
result	NULL
in	NULL
free	NULL
IxBa	NULL
being	NULL
recognized	NULL
and	NULL
degraded	NULL
.	NULL

We	NULL
do	NULL
not	NULL
favor	NULL
this	NULL
explanation	NULL
even	NULL
though	NULL
there	NULL
is	NULL
no	NULL
direct	NULL
evidence	NULL
to	NULL
rule	NULL
it	NULL
out	NULL
.	NULL

In	NULL
our	NULL
experience	NULL
isolated	NULL
IxBa	NULL
&	NULL
-containing	NULL
complexes	NULL
are	NULL
stable	NULL
for	NULL
days	NULL
and	NULL
survive	NULL
multiple	NULL
purification	NULL
procedures	NULL
.	NULL

(	NULL
ii	NULL
)	NULL
Perhaps	NULL
complexed	NULL
IxBa	NULL
is	NULL
inherently	NULL
unstable	NULL
due	NULL
to	NULL
some	NULL
feature	NULL
of	NULL
its	NULL
structure	NULL
that	NULL
marks	NULL
it	NULL
for	NULL
rapid	NULL
turnover	NULL
.	NULL

In	NULL
that	NULL
case	NULL
we	NULL
need	NULL
not	NULL
invoke	NULL
a	NULL
separate	NULL
dissociation	NULL
event	NULL
,	NULL
but	NULL
only	NULL
recognition	NULL
and	NULL
degradation	NULL
.	NULL

However	NULL
,	NULL
this	NULL
theory	NULL
requires	NULL
a	NULL
second	NULL
mechanism	NULL
to	NULL
account	NULL
for	NULL
the	NULL
response	NULL
of	NULL
IxBa	NULL
to	NULL
activating	NULL
signals	NULL
.	NULL

(	NULL
iii	NULL
)	NULL
Alternatively	NULL
,	NULL
perhaps	NULL
the	NULL
complexed	NULL
molecule	NULL
is	NULL
stable	NULL
until	NULL
it	NULL
is	NULL
modified	NULL
in	NULL
some	NULL
way	NULL
by	NULL
normal	NULL
cellular	NULL
processes	NULL
.	NULL

For	NULL
example	NULL
,	NULL
perhaps	NULL
the	NULL
kinase	NULL
that	NULL
phosphorylates	NULL
IxBa	NULL
in	NULL
an	NULL
activated	NULL
cell	NULL
operates	NULL
constitutively	NULL
at	NULL
a	NULL
low	NULL
level	NULL
in	NULL
the	NULL
unstimulated	NULL
cell	NULL
.	NULL

Phosphorylation	NULL
of	NULL
IxBa	NULL
might	NULL
result	NULL
in	NULL
its	NULL
recognition	NULL
and	NULL
degradation	NULL
,	NULL
perhaps	NULL
following	NULL
its	NULL
dissociation	NULL
from	NULL
the	NULL
complex	NULL
.	NULL

This	NULL
is	NULL
an	NULL
attractive	NULL
hypothesis	NULL
because	NULL
it	NULL
postulates	NULL
Instability	NULL
of	NULL
IxBa	NULL
complexes	NULL
a	NULL
single	NULL
mechanism	NULL
to	NULL
account	NULL
for	NULL
events	NULL
in	NULL
both	NULL
the	NULL
unstimulated	NULL
and	NULL
the	NULL
activated	NULL
cell	NULL
,	NULL
but	NULL
there	NULL
is	NULL
as	NULL
yet	NULL
no	NULL
evidence	NULL
to	NULL
support	NULL
it	NULL
.	NULL

Whatever	NULL
the	NULL
basis	NULL
for	NULL
IxBa	NULL
's	NULL
instability	NULL
in	NULL
the	NULL
cell	NULL
lines	NULL
examined	NULL
here	NULL
,	NULL
there	NULL
is	NULL
no	NULL
a	NULL
prior	NULL
?	NULL

reason	NULL
to	NULL
think	NULL
that	NULL
all	NULL
cells	NULL
have	NULL
such	NULL
unstable	NULL
IxBa	NULL
.	NULL

For	NULL
example	NULL
,	NULL
if	NULL
the	NULL
hypothetical	NULL
kinase	NULL
mentioned	NULL
above	NULL
has	NULL
little	NULL
or	NULL
no	NULL
constitutive	NULL
activity	NULL
,	NULL
complexed	NULL
IxBa	NULL
might	NULL
be	NULL
more	NULL
stable	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
it	NULL
is	NULL
important	NULL
to	NULL
stress	NULL
that	NULL
the	NULL
results	NULL
we	NULL
present	NULL
are	NULL
not	NULL
limited	NULL
to	NULL
the	NULL
WEHI	NULL
231	NULL
B	NULL
cell	NULL
line	NULL
,	NULL
but	NULL
pertain	NULL
to	NULL
a	NULL
pre-B	NULL
,	NULL
a	NULL
T	NULL
,	NULL
a	NULL
plasmacytoma	NULL
and	NULL
an	NULL
epithelial	NULL
cell	NULL
line	NULL
as	NULL
well	NULL
.	NULL

The	NULL
cost	NULL
of	NULL
maintaining	NULL
this	NULL
system	NULL
is	NULL
considerable	NULL
.	NULL

A	NULL
1	NULL
h	NULL
half-life	NULL
for	NULL
IxBa	NULL
means	NULL
that	NULL
it	NULL
will	NULL
be	NULL
replaced	NULL
in	NULL
half	NULL
of	NULL
all	NULL
the	NULL
complexes	NULL
every	NULL
hour	NULL
,	NULL
even	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
an	NULL
activating	NULL
signal	NULL
.	NULL

Looked	NULL
at	NULL
another	NULL
way	NULL
,	NULL
if	NULL
the	NULL
half-life	NULL
of	NULL
IxBa-bound	NULL
c-rel	NULL
and	NULL
p65	NULL
is	NULL
~8	NULL
h	NULL
,	NULL
IxBa	NULL
is	NULL
produced	NULL
at	NULL
at	NULL
least	NULL
8	NULL
times	NULL
the	NULL
rate	NULL
of	NULL
their	NULL
synthesis	NULL
.	NULL

What	NULL
is	NULL
the	NULL
advantage	NULL
to	NULL
the	NULL
cell	NULL
of	NULL
such	NULL
a	NULL
seemingly	NULL
wasteful	NULL
system	NULL
?	NULL

One	NULL
possibility	NULL
is	NULL
that	NULL
it	NULL
generates	NULL
the	NULL
low	NULL
level	NULL
of	NULL
NF-xB	NULL
activity	NULL
that	NULL
is	NULL
presumably	NULL
necessary	NULL
even	NULL
in	NULL
unstimulated	NULL
cells	NULL
.	NULL

At	NULL
a	NULL
minimum	NULL
,	NULL
dividing	NULL
cells	NULL
must	NULL
double	NULL
their	NULL
NF-xB	NULL
content	NULL
once	NULL
per	NULL
cycle	NULL
,	NULL
and	NULL
active	NULL
NF-xB	NULL
is	NULL
probably	NULL
necessary	NULL
to	NULL
accomplish	NULL
this	NULL
[	NULL
the	NULL
genes	NULL
for	NULL
both	NULL
p105	NULL
and	NULL
c-rel	NULL
have	NULL
xB	NULL
sites	NULL
in	NULL
their	NULL
promoter	NULL
regions	NULL
(	NULL
Hannink	NULL
and	NULL
Temin	NULL
,	NULL
1990	NULL
;	NULL
Capobianco	NULL
and	NULL
Gilmore	NULL
,	NULL
1991	NULL
;	NULL
Ten	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
T.Kochel	NULL
and	NULL
N.R.Rice	NULL
,	NULL
unpublished	NULL
)	NULL
]	NULL
.	NULL

The	NULL
continual	NULL
turnover	NULL
of	NULL
IxBa	NULL
may	NULL
provide	NULL
the	NULL
opportunity	NULL
for	NULL
small	NULL
amounts	NULL
of	NULL
liberated	NULL
c-rel/p65/p50	NULL
to	NULL
enter	NULL
the	NULL
nucleus	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
if	NULL
the	NULL
complexes	NULL
were	NULL
very	NULL
stable	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
an	NULL
activation	NULL
signal	NULL
,	NULL
there	NULL
would	NULL
be	NULL
no	NULL
active	NULL
NF-xB	NULL
for	NULL
'house-keeping	NULL
'	NULL
purposes	NULL
.	NULL

A	NULL
second	NULL
possible	NULL
advantage	NULL
of	NULL
the	NULL
system	NULL
follows	NULL
from	NULL
the	NULL
high	NULL
rate	NULL
of	NULL
IxBa	NULL
synthesis	NULL
,	NULL
which	NULL
may	NULL
provide	NULL
the	NULL
ability	NULL
to	NULL
curtail	NULL
NF-xB	NULL
activity	NULL
rapidly	NULL
once	NULL
the	NULL
activating	NULL
signal	NULL
subsides	NULL
.	NULL

It	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
IxBa	NULL
is	NULL
not	NULL
only	NULL
the	NULL
major	NULL
cytoplasmic	NULL
inhibitor	NULL
of	NULL
NF-xB	NULL
,	NULL
but	NULL
that	NULL
it	NULL
is	NULL
also	NULL
responsible	NULL
for	NULL
turning	NULL
off	NULL
active	NULL
NF-xB	NULL
in	NULL
the	NULL
nucleus	NULL
(	NULL
Zabel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

The	NULL
hypothesis	NULL
is	NULL
that	NULL
some	NULL
excess	NULL
IxBa	NULL
molecules	NULL
may	NULL
enter	NULL
the	NULL
nucleus	NULL
,	NULL
bind	NULL
to	NULL
active	NULL
NF-xB	NULL
and	NULL
release	NULL
it	NULL
from	NULL
DNA	NULL
.	NULL

However	NULL
,	NULL
there	NULL
can	NULL
only	NULL
be	NULL
excess	NULL
IxBa	NULL
if	NULL
its	NULL
rate	NULL
of	NULL
synthesis	NULL
exceeds	NULL
that	NULL
of	NULL
the	NULL
c-re/	NULL
and	NULL
p65	NULL
to	NULL
which	NULL
it	NULL
binds	NULL
.	NULL

If	NULL
their	NULL
rates	NULL
of	NULL
synthesis	NULL
were	NULL
the	NULL
same	NULL
,	NULL
all	NULL
new	NULL
IxBa	NULL
would	NULL
bind	NULL
to	NULL
new	NULL
c-rel/p65	NULL
:	NULL
there	NULL
would	NULL
never	NULL
be	NULL
uncomplexed	NULL
inhibitor	NULL
,	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
activating	NULL
agent	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
the	NULL
rate	NULL
of	NULL
synthesis	NULL
of	NULL
IxBa	NULL
considerably	NULL
exceeds	NULL
that	NULL
of	NULL
the	NULL
c-rel/p65	NULL
to	NULL
which	NULL
it	NULL
binds	NULL
.	NULL

We	NULL
showed	NULL
that	NULL
under	NULL
'resting	NULL
'	NULL
conditions	NULL
enough	NULL
IxBa	NULL
is	NULL
made	NULL
not	NULL
only	NULL
to	NULL
bind	NULL
new	NULL
c-rel/p65	NULL
,	NULL
but	NULL
also	NULL
to	NULL
replace	NULL
old	NULL
IxBa	NULL
in	NULL
pre-existing	NULL
dimers	NULL
.	NULL

Under	NULL
activating	NULL
conditions	NULL
,	NULL
however	NULL
,	NULL
some	NULL
or	NULL
many	NULL
of	NULL
those	NULL
pre-existing	NULL
dimers	NULL
will	NULL
have	NULL
left	NULL
the	NULL
cytoplasm	NULL
for	NULL
the	NULL
nucleus	NULL
,	NULL
thus	NULL
creating	NULL
an	NULL
imbalance	NULL
between	NULL
the	NULL
amount	NULL
of	NULL
newly	NULL
synthesized	NULL
IxBa	NULL
and	NULL
its	NULL
available	NULL
targets	NULL
.	NULL

If	NULL
some	NULL
of	NULL
the	NULL
excess	NULL
IxBa	NULL
escapes	NULL
degradation	NULL
and	NULL
enters	NULL
the	NULL
nucleus	NULL
,	NULL
it	NULL
could	NULL
inactivate	NULL
some	NULL
of	NULL
the	NULL
translocated	NULL
dimers	NULL
.	NULL

Such	NULL
a	NULL
system	NULL
ensures	NULL
that	NULL
maintenance	NULL
of	NULL
NF-xB	NULL
activity	NULL
depends	NULL
on	NULL
continued	NULL
migration	NULL
of	NULL
liberated	NULL
dimers	NULL
from	NULL
cytoplasm	NULL
to	NULL
nucleus	NULL
,	NULL
i.e	NULL
.	NULL

on	NULL
the	NULL
continued	NULL
presence	NULL
of	NULL
the	NULL
activating	NULL
signal	NULL
.	NULL

If	NULL
the	NULL
stimulus	NULL
abates	NULL
and	NULL
no	NULL
new	NULL
dimers	NULL
reach	NULL
the	NULL
nucleus	NULL
,	NULL
the	NULL
nuclear	NULL
IxBa	NULL
can	NULL
turn	NULL
off	NULL
the	NULL
response	NULL
very	NULL
quickly	NULL
.	NULL

Thus	NULL
,	NULL
even	NULL
before	NULL
the	NULL
increased	NULL
transcription	NULL
of	NULL
the	NULL
IxBa	NULL
gene	NULL
that	NULL
is	NULL
induced	NULL
by	NULL
activating	NULL
agents	NULL
(	NULL
Haskill	NULL
er	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Tewari	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Brown	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Sun	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
,	NULL
the	NULL
4693	NULL
N.R.Rice	NULL
and	NULL
M.K.Ernst	NULL
system	NULL
is	NULL
very	NULL
responsive	NULL
to	NULL
changes	NULL
in	NULL
the	NULL
environment	NULL
.	NULL

The	NULL
important	NULL
point	NULL
is	NULL
that	NULL
it	NULL
requires	NULL
that	NULL
IxBa	NULL
and	NULL
its	NULL
target	NULL
p65	NULL
and	NULL
c-rel	NULL
molecules	NULL
be	NULL
synthesized	NULL
at	NULL
different	NULL
rates	NULL
.	NULL

Thus	NULL
,	NULL
viewing	NULL
this	NULL
regulatory	NULL
sytem	NULL
as	NULL
a	NULL
whole	NULL
,	NULL
storage	NULL
of	NULL
active	NULL
transcription	NULL
factor	NULL
in	NULL
the	NULL
cytoplasm	NULL
enables	NULL
instantaneous	NULL
gene	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
cell	NULL
stimulation	NULL
.	NULL

Constitutive	NULL
synthesis	NULL
of	NULL
excess	NULL
inhibitor	NULL
enables	NULL
instantaneous	NULL
damping	NULL
of	NULL
activity	NULL
upon	NULL
cessation	NULL
or	NULL
diminution	NULL
of	NULL
stimulation	NULL
.	NULL

Materials	NULL
and	NULL
methods	NULL
Cells	NULL
and	NULL
reagents	NULL
Mouse	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
and	NULL
,	NULL
in	NULL
the	NULL
case	NULL
of	NULL
702/3	NULL
,	NULL
50	NULL
4M	NULL
2-mercaptoethanol	NULL
.	NULL

The	NULL
serum	NULL
contained	NULL
<	NULL
10	NULL
endotoxin	NULL
units	NULL
per	NULL
ml	NULL
by	NULL
the	NULL
limulus	NULL
amebocyte	NULL
lysate	NULL
assay	NULL
(	NULL
Gibco	NULL
)	NULL
.	NULL

Human	NULL
293	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
DMEM	NULL
plus	NULL
10	NULL
%	NULL
serum	NULL
.	NULL

Serum-free	NULL
medium	NULL
(	NULL
Aim-V	NULL
)	NULL
was	NULL
obtained	NULL
from	NULL
Gibco	NULL
,	NULL
Escherichia	NULL
coli	NULL
LPS	NULL
from	NULL
Sigma	NULL
,	NULL
and	NULL
cycloheximide	NULL
from	NULL
Boehringer-Mannheim	NULL
.	NULL

Antisera	NULL
All	NULL
of	NULL
the	NULL
antisera	NULL
were	NULL
raised	NULL
in	NULL
rabbits	NULL
against	NULL
synthetic	NULL
peptides	NULL
coupled	NULL
to	NULL
keyhole	NULL
limpet	NULL
hemocyanin	NULL
.	NULL

The	NULL
peptide	NULL
sequences	NULL
for	NULL
#	NULL
1050	NULL
,	NULL
1051	NULL
,	NULL
1135	NULL
,	NULL
1140	NULL
,	NULL
1157	NULL
,	NULL
1207	NULL
,	NULL
1226	NULL
and	NULL
1258	NULL
were	NULL
published	NULL
previously	NULL
(	NULL
Kochel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Rice	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

#	NULL
1158	NULL
is	NULL
NH	NULL
,	NULL
-Val-Thr-Lys-Asn-Asp-Pro-Tyr-Lys-Pro-His-Pro-His-Asp-Leu-Val-Gly-Lys-Cys	NULL
(	NULL
residues	NULL
66-82	NULL
of	NULL
murine	NULL
c-re	NULL
?	NULL
)	NULL

,	NULL
and	NULL
#	NULL
1266	NULL
is	NULL
NH	NULL
,	NULL
-Cys-Glu-Gin-Leu-Ser-Asp-Pro-Phe-Thr-Tyr-Gly-Phe-Phe-Lys-le	NULL
(	NULL
residues	NULL
573-586	NULL
of	NULL
murine	NULL
c-re/	NULL
)	NULL
(	NULL
Bull	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

#	NULL
1263	NULL
is	NULL
NH-Ala-Asp-Asp-Asp-Pro-Tyr-Gly-Thr-Gly-Gin-Met-Phe-His-Leu-Cys	NULL
(	NULL
residues	NULL
2-15	NULL
of	NULL
murine	NULL
p105	NULL
)	NULL
(	NULL
Ghosh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

A	NULL
cysteine	NULL
residue	NULL
at	NULL
the	NULL
N-	NULL
or	NULL
C-terminus	NULL
of	NULL
#	NULL
1158	NULL
,	NULL
#	NULL
1266	NULL
and	NULL
#	NULL
1263	NULL
was	NULL
added	NULL
to	NULL
allow	NULL
coupling	NULL
to	NULL
hemocyanin	NULL
,	NULL
as	NULL
described	NULL
by	NULL
Liu	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1979	NULL
)	NULL
.	NULL

Peptides	NULL
were	NULL
purchased	NULL
from	NULL
Multiple	NULL
Peptide	NULL
Systems	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Metabolic	NULL
labeling	NULL
Cells	NULL
were	NULL
washed	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
and	NULL
then	NULL
resuspended	NULL
in	NULL
methionine	NULL
and	NULL
cysteine-free	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
dialyzed	NULL
fetal	NULL
calf	NULL
serum	NULL
and	NULL
[	NULL
*5S	NULL
)	NULL
methionine	NULL
and	NULL
(	NULL
each	NULL
at	NULL
50-100	NULL
gCi/ml	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
30-60	NULL
min	NULL
.	NULL

The	NULL
dialyzed	NULL
serum	NULL
was	NULL
omitted	NULL
when	NULL
702/3	NULL
cells	NULL
propagated	NULL
in	NULL
serum-free	NULL
medium	NULL
were	NULL
labeled	NULL
.	NULL

Immunoprecipitations	NULL
For	NULL
whole	NULL
cell	NULL
extracts	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
RIPA	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
150	NULL
mM	NULL
sodium	NULL
chloride	NULL
,	NULL
2	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
%	NULL
sodium	NULL
deoxycholate	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
0.25	NULL
%	NULL
SDS	NULL
)	NULL
.	NULL

For	NULL
cytoplasmic	NULL
extracts	NULL
TNT-E	NULL
was	NULL
used	NULL
(	NULL
20	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
50	NULL
mM	NULL
sodium	NULL
chloride	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
5	NULL
mM	NULL
EDTA	NULL
)	NULL
.	NULL

Lysates	NULL
were	NULL
cleared	NULL
by	NULL
centrifuging	NULL
at	NULL
10	NULL
000	NULL
g	NULL
for	NULL
10	NULL
min	NULL
.	NULL

For	NULL
single-cycle	NULL
immunoprecipitations	NULL
,	NULL
lysate	NULL
from	NULL
~10	NULL
``	NULL
cells	NULL
was	NULL
incubated	NULL
overnight	NULL
at	NULL
4°C	NULL
with	NULL
10	NULL
al	NULL
antiserum	NULL
(	NULL
or	NULL
5	NULL
al	NULL
for	NULL
702/3	NULL
and	NULL
Jurkat	NULL
cells	NULL
)	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
1	NULL
ml	NULL
.	NULL

Precipitates	NULL
were	NULL
collected	NULL
on	NULL
protein	NULL
A-Sepharose	NULL
(	NULL
Pharmacia	NULL
)	NULL
,	NULL
washed	NULL
in	NULL
TNT-E	NULL
,	NULL
boiled	NULL
in	NULL
loading	NULL
dye	NULL
and	NULL
electrophoresed	NULL
on	NULL
10	NULL
%	NULL
SDS-polyacrylamide	NULL
gels	NULL
.	NULL

Gels	NULL
were	NULL
soaked	NULL
in	NULL
1	NULL
M	NULL
sodium	NULL
salicylate	NULL
for	NULL
30	NULL
min	NULL
,	NULL
dried	NULL
and	NULL
autoradiographed	NULL
at	NULL
-70°C	NULL
.	NULL

For	NULL
two-cycle	NULL
immunoprecipitations	NULL
,	NULL
lysate	NULL
from	NULL
cells	NULL
was	NULL
incubated	NULL
with	NULL
100	NULL
al	NULL
antiserum	NULL
(	NULL
or	NULL
50	NULL
al	NULL
for	NULL
702/3	NULL
and	NULL
Jurkat	NULL
cells	NULL
)	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
~5	NULL
ml	NULL
and	NULL
precipitates	NULL
were	NULL
collected	NULL
on	NULL
protein	NULL
A-Sepharose	NULL
.	NULL

The	NULL
washed	NULL
precipitate	NULL
was	NULL
resuspended	NULL
in	NULL
about	NULL
0.5	NULL
ml	NULL
TNT-E	NULL
and	NULL
incubated	NULL
overnight	NULL
at	NULL
4°C	NULL
with	NULL
100	NULL
ug	NULL
(	NULL
or	NULL
50	NULL
ug	NULL
)	NULL
cognate	NULL
peptide	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
collected	NULL
,	NULL
aliquoted	NULL
,	NULL
reprecipitated	NULL
with	NULL
other	NULL
antisera	NULL
and	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
as	NULL
above	NULL
.	NULL

immunoblotting	NULL
Cell	NULL
pellets	NULL
were	NULL
washed	NULL
in	NULL
PBS	NULL
,	NULL
then	NULL
in	NULL
hypotonic	NULL
buffer	NULL
(	NULL
HB	NULL
)	NULL
(	NULL
25	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
1	NULL
mM	NULL
magnesium	NULL
chloride	NULL
,	NULL
5	NULL
mM	NULL
potassium	NULL
chloride	NULL
)	NULL
and	NULL
then	NULL
incubated	NULL
in	NULL
HB	NULL
for	NULL
15	NULL
min	NULL
on	NULL
ice	NULL
.	NULL

An	NULL
equal	NULL
volume	NULL
of	NULL
HB	NULL
containing	NULL
1	NULL
%	NULL
NP-40	NULL
was	NULL
added	NULL
,	NULL
and	NULL
nuclei	NULL
were	NULL
pelleted	NULL
by	NULL
centrifugation	NULL
at	NULL
500	NULL
g	NULL
for	NULL
5	NULL
min	NULL
.	NULL

The	NULL
supernatant	NULL
constitutes	NULL
the	NULL
cytoplasmic	NULL
fraction	NULL
.	NULL

Nuclei	NULL
were	NULL
resuspended	NULL
in	NULL
20	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
8	NULL
,	NULL
25	NULL
%	NULL
glycerol	NULL
,	NULL
0.42	NULL
M	NULL
sodium	NULL
chloride	NULL
,	NULL
1.5	NULL
mM	NULL
magnesium	NULL
chloride	NULL
,	NULL
vortexed	NULL
vigorously	NULL
and	NULL
agitated	NULL
at	NULL
4°C	NULL
for	NULL
~30	NULL
min	NULL
.	NULL

Debris	NULL
was	NULL
pelleted	NULL
at	NULL
900	NULL
g	NULL
for	NULL
5	NULL
min	NULL
;	NULL
the	NULL
supernatant	NULL
constitutes	NULL
the	NULL
nuclear	NULL
fraction	NULL
.	NULL

Equal	NULL
cell	NULL
equivalents	NULL
of	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
fractions	NULL
were	NULL
added	NULL
to	NULL
loading	NULL
dye	NULL
,	NULL
boiled	NULL
,	NULL
electrophoresed	NULL
on	NULL
a	NULL
10	NULL
%	NULL
gel	NULL
and	NULL
transferred	NULL
to	NULL
Immobilon-P	NULL
(	NULL
Millipore	NULL
)	NULL
.	NULL

Filter	NULL
strips	NULL
were	NULL
incubated	NULL
in	NULL
primary	NULL
antibody	NULL
for	NULL
30	NULL
min	NULL
(	NULL
1:1000	NULL
dilution	NULL
for	NULL
1050	NULL
and	NULL
4694	NULL
1226	NULL
;	NULL
1:2000	NULL
for	NULL
1158	NULL
and	NULL
1157	NULL
)	NULL
,	NULL
then	NULL
in	NULL
peroxidase-conjugated	NULL
goat	NULL
anti-rabbit	NULL
IgG	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
at	NULL
1:10	NULL
000	NULL
for	NULL
30	NULL
min	NULL
and	NULL
then	NULL
analyzed	NULL
using	NULL
Amersham	NULL
's	NULL
enhanced	NULL
chemiluminescence	NULL
system	NULL
.	NULL

Cell	NULL
fractionation	NULL
for	NULL
EMSA	NULL
108	NULL
cells	NULL
were	NULL
pelleted	NULL
,	NULL
washed	NULL
in	NULL
PBS	NULL
and	NULL
resuspended	NULL
in	NULL
1	NULL
ml	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mM	NULL
HEPES	NULL
,	NULL
pH	NULL
7.6	NULL
,	NULL
15	NULL
mM	NULL
KCI	NULL
,	NULL
2	NULL
mM	NULL
MgC	NULL
)	NULL
;	NULL
,	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
0.1	NULL
%	NULL
NP-40	NULL
)	NULL
.	NULL

After	NULL
10	NULL
min	NULL
on	NULL
ice	NULL
,	NULL
the	NULL
lysate	NULL
was	NULL
centrifuged	NULL
at	NULL
500	NULL
g	NULL
for	NULL
10	NULL
min	NULL
;	NULL
the	NULL
supernatant	NULL
is	NULL
the	NULL
cytoplasmic	NULL
fraction	NULL
.	NULL

The	NULL
nuclear	NULL
pellet	NULL
was	NULL
resuspended	NULL
in	NULL
20	NULL
gl	NULL
buffer	NULL
B	NULL
(	NULL
25	NULL
mM	NULL
HEPES	NULL
,	NULL
pH	NULL
7.6	NULL
,	NULL
1	NULL
M	NULL
KCI	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
)	NULL
with	NULL
frequent	NULL
vortexing	NULL
for	NULL
15	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

After	NULL
centrifuging	NULL
at	NULL
20	NULL
000	NULL
g	NULL
for	NULL
20	NULL
min	NULL
,	NULL
the	NULL
supernatant	NULL
was	NULL
diluted	NULL
with	NULL
buffer	NULL
C	NULL
(	NULL
25	NULL
mM	NULL
HEPES	NULL
,	NULL
pH	NULL
7.6	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
)	NULL
at	NULL
a	NULL
ratio	NULL
of	NULL
1	NULL
part	NULL
supernatant	NULL
to	NULL
3.75	NULL
parts	NULL
buffer	NULL
C.	NULL
This	NULL
mixture	NULL
constitutes	NULL
the	NULL
nuclear	NULL
extract	NULL
.	NULL

Oligonucleotides	NULL
for	NULL
EMSA	NULL
Oligonucleotides	NULL
were	NULL
synthesized	NULL
by	NULL
an	NULL
Applied	NULL
Biosystems	NULL
synthesizer	NULL
and	NULL
were	NULL
used	NULL
without	NULL
purification	NULL
.	NULL

The	NULL
sequences	NULL
are	NULL
:	NULL
murine	NULL
intronic	NULL
kappa	NULL
chain	NULL
xB	NULL
site	NULL
(	NULL
underlined	NULL
)	NULL
(	NULL
Sen	NULL
and	NULL
Baltimore	NULL
,	NULL
19862	NULL
)	NULL
with	NULL
artificial	NULL
flanking	NULL
sequences	NULL
,	NULL
5-GAATTCCTGGGGGACTITTCCGAGAATTC-3	NULL
'	NULL
;	NULL
the	NULL
IL-6	NULL
promoter	NULL
xB	NULL
site	NULL
(	NULL
underlined	NULL
)	NULL
,	NULL
with	NULL
its	NULL
natural	NULL
flanking	NULL
sequences	NULL
,	NULL
5'-TCAAATGTGGGATTTTCCCATGAGTCT-3	NULL
'	NULL
(	NULL
Libermann	NULL
and	NULL
Baltimore	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

After	NULL
renaturing	NULL
complementary	NULL
strands	NULL
,	NULL
200	NULL
ng	NULL
DNA	NULL
was	NULL
labeled	NULL
in	NULL
10	NULL
gl	NULL
by	NULL
incubation	NULL
with	NULL
[	NULL
P	NULL
]	NULL
ATP	NULL
and	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
.	NULL

This	NULL
mixture	NULL
was	NULL
brought	NULL
up	NULL
to	NULL
200	NULL
#	NULL
1	NULL
with	NULL
10	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
and	NULL
the	NULL
probe	NULL
was	NULL
purified	NULL
twice	NULL
on	NULL
a	NULL
G-50	NULL
spin	NULL
column	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
The	NULL
binding	NULL
reaction	NULL
mixture	NULL
was	NULL
10	NULL
mM	NULL
HEPES	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
80	NULL
mM	NULL
KCI	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
EGTA	NULL
,	NULL
6	NULL
%	NULL
glycerol	NULL
,	NULL
0.5	NULL
ug	NULL
poly	NULL
(	NULL
dIC	NULL
)	NULL
,	NULL
0.5	NULL
ug	NULL
sonicated	NULL
double-stranded	NULL
salmon	NULL
sperm	NULL
DNA	NULL
,	NULL
32P-labeled	NULL
oligonucleotide	NULL
(	NULL
=	NULL
1	NULL
ng	NULL
,	NULL
~5000-10	NULL
000	NULL
c.p.m	NULL
.	NULL
)	NULL

and	NULL
nuclear	NULL
extract	NULL
(	NULL
=	NULL
5	NULL
ug	NULL
protein	NULL
)	NULL
.	NULL

The	NULL
mixture	NULL
was	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
30	NULL
min	NULL
.	NULL

For	NULL
supershift	NULL
assays	NULL
,	NULL
the	NULL
reaction	NULL
mixture	NULL
minus	NULL
the	NULL
probe	NULL
was	NULL
incubated	NULL
with	NULL
1	NULL
pl	NULL
antiserum	NULL
for	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

The	NULL
32P-labeled	NULL
oligonucleotide	NULL
was	NULL
then	NULL
added	NULL
and	NULL
incubation	NULL
continued	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Products	NULL
were	NULL
analyzed	NULL
on	NULL
5	NULL
%	NULL
acrylamide	NULL
gels	NULL
made	NULL
up	NULL
in	NULL
0.5	NULL
x	NULL
TBE	NULL
and	NULL
0.001	NULL
%	NULL
NP-40	NULL
.	NULL

Transfection	NULL
experiments	NULL
Human	NULL
293	NULL
cells	NULL
in	NULL
6	NULL
cm	NULL
dishes	NULL
were	NULL
transfected	NULL
by	NULL
the	NULL
calcium	NULL
phosphate	NULL
procedure	NULL
with	NULL
4	NULL
ug	NULL
plasmid	NULL
DNA	NULL
.	NULL

48	NULL
h	NULL
later	NULL
the	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
medium	NULL
containing	NULL
[	NULL
**S	NULL
}	NULL
methionine	NULL
(	NULL
50	NULL
Ci/m	NULL
!	NULL
)	NULL

for	NULL
1	NULL
h	NULL
and	NULL
then	NULL
chased	NULL
in	NULL
non-radioactive	NULL
medium	NULL
.	NULL

Individual	NULL
dishes	NULL
were	NULL
harvested	NULL
at	NULL
various	NULL
times	NULL
thereafter	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
in	NULL
TNT	NULL
-E	NULL
and	NULL
immunoprecipitated	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Figure	NULL
8	NULL
.	NULL

For	NULL
the	NULL
top	NULL
two	NULL
panels	NULL
in	NULL
that	NULL
figure	NULL
each	NULL
lane	NULL
represents	NULL
the	NULL
precipitate	NULL
from	NULL
about	NULL
10	NULL
%	NULL
of	NULL
a	NULL
dish	NULL
,	NULL
while	NULL
for	NULL
the	NULL
bottom	NULL
panel	NULL
,	NULL
each	NULL
lane	NULL
represents	NULL
the	NULL
precipitate	NULL
from	NULL
~50	NULL
%	NULL
of	NULL
a	NULL
dish	NULL
.	NULL

Acknowledgements	NULL
We	NULL
are	NULL
grateful	NULL
to	NULL
Craig	NULL
Rosen	NULL
and	NULL
Steve	NULL
Haskill	NULL
for	NULL
p65	NULL
and	NULL
IxBa	NULL
expression	NULL
vectors	NULL
.	NULL

We	NULL
thank	NULL
Dmitri	NULL
Kuprash	NULL
and	NULL
Sergei	NULL
Nedospasov	NULL
for	NULL
sharing	NULL
their	NULL
methodology	NULL
for	NULL
EMSA	NULL
,	NULL
John	NULL
O'Shea	NULL
,	NULL
Alan	NULL
Rein	NULL
and	NULL
Bob	NULL
Stephens	NULL
for	NULL
helpful	NULL
discussions	NULL
,	NULL
Marilyn	NULL
Powers	NULL
for	NULL
synthesis	NULL
of	NULL
oligonucleotides	NULL
,	NULL
Pat	NULL
Wesdock	NULL
for	NULL
antiserum	NULL
production	NULL
,	NULL
and	NULL
Carol	NULL
Shawver	NULL
for	NULL
preparation	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

Research	NULL
sponsored	NULL
by	NULL
the	NULL
National	NULL
Cancer	NULL
Institute	NULL
,	NULL
DHHS	NULL
under	NULL
contract	NULL
no	NULL
.	NULL

NO1-CO-74101	NULL
with	NULL
ABL	NULL
.	NULL

The	NULL
contents	NULL
of	NULL
this	NULL
publication	NULL
do	NULL
not	NULL
necessarily	NULL
reflect	NULL
the	NULL
views	NULL
or	NULL
policies	NULL
of	NULL
the	NULL
Department	NULL
of	NULL
Health	NULL
and	NULL
Human	NULL
Services	NULL
,	NULL
nor	NULL
does	NULL
mention	NULL
of	NULL
trade	NULL
names	NULL
,	NULL
commercial	NULL
products	NULL
,	NULL
or	NULL
organizations	NULL
imply	NULL
endorsement	NULL
by	NULL
the	NULL
US	NULL
Government	NULL
.	NULL

References	NULL
Bacuerle	NULL
,	NULL
P.A	NULL
.	NULL

and	NULL
Baltimore	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Cell	NULL
,	NULL
53	NULL
,	NULL
211-217	NULL
.	NULL

Bacuerie	NULL
,	NULL
P.A	NULL
.	NULL

and	NULL
Baltimore	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

,	NULL
3	NULL
,	NULL
1689-1698	NULL
.	NULL

Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Walker	NULL
,	NULL
W.H	NULL
.	NULL

,	NULL
Doerre	NULL
,	NULL
S.	NULL
,	NULL
Sista	NULL
,	NULL
P.	NULL
,	NULL
Mollitor	NULL
,	NULL
J.A	NULL
.	NULL

,	NULL
Dixon	NULL
,	NULL
E.P	NULL
.	NULL

,	NULL
Peffer	NULL
,	NULL
N.J.	NULL
,	NULL
Hannink	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Greene	NULL
,	NULL
W.C.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
,	NULL
63	NULL
,	NULL
803-814	NULL
.	NULL

Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Dixon	NULL
,	NULL
E.P	NULL
.	NULL

,	NULL
Peffer	NULL
,	NULL
N.J.	NULL
,	NULL
Bogerd	NULL
,	NULL
H.	NULL
,	NULL
Doerre	NULL
,	NULL
S.	NULL
,	NULL
Stein	NULL
,	NULL
B	NULL
.	NULL

and	NULL
Greene	NULL
,	NULL
W.C.	NULL
(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
89	NULL
,	NULL
1875-1879	NULL
.	NULL

Beg	NULL
,	NULL
A.A.	NULL
,	NULL
Ruben	NULL
,	NULL
S.M	NULL
.	NULL

,	NULL
Scheinman	NULL
,	NULL
R.I.	NULL
,	NULL
Haskill	NULL
,	NULL
S.	NULL
,	NULL
Rosen	NULL
,	NULL
C.A	NULL
.	NULL

and	NULL
Baldwin	NULL
,	NULL
A.S.	NULL
,	NULL
Jr	NULL
(	NULL
1992	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

,	NULL
6	NULL
,	NULL
1899-1913	NULL
.	NULL

Beg	NULL
,	NULL
A.A.	NULL
,	NULL
Finco	NULL
,	NULL
T.S	NULL
.	NULL

,	NULL
Nantermet	NULL
,	NULL
P	NULL
.	NULL

V.	NULL
and	NULL
Baldwin	NULL
,	NULL
A.S.	NULL
,	NULL
Jr	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
13	NULL
,	NULL
3301-3310	NULL
.	NULL

Bours	NULL
,	NULL
V.	NULL
,	NULL
Villalobos	NULL
,	NULL
J.	NULL
,	NULL
Burd	NULL
,	NULL
P.R	NULL
.	NULL

,	NULL
Kelly	NULL
,	NULL
K	NULL
.	NULL

and	NULL
Siebenlist	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Nature	NULL
,	NULL
348	NULL
,	NULL
76-79	NULL
.	NULL

Bours	NULL
,	NULL
V.	NULL
,	NULL
Burd	NULL
,	NULL
P.R	NULL
.	NULL

,	NULL
Brown	NULL
,	NULL
K.	NULL
,	NULL
Villalobos	NULL
,	NULL
J.	NULL
,	NULL
Park	NULL
,	NULL
S.	NULL
,	NULL
Ryseck	NULL
,	NULL
R.-P.	NULL
,	NULL
Bravo	NULL
,	NULL
R.	NULL
,	NULL
Kelly	NULL
,	NULL
K	NULL
.	NULL

and	NULL
Siebenlist	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
12	NULL
,	NULL
685-695	NULL
.	NULL

Brown	NULL
,	NULL
K.	NULL
,	NULL
Park	NULL
,	NULL
S.	NULL
,	NULL
Kanno	NULL
,	NULL
T.	NULL
,	NULL
Franzoso	NULL
,	NULL
G	NULL
.	NULL

and	NULL
Siebenlist	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
90	NULL
,	NULL
2532-2536	NULL
.	NULL

Bull	NULL
,	NULL
P.	NULL
,	NULL
Morley	NULL
,	NULL
K.L	NULL
.	NULL

,	NULL
Hoekstra	NULL
,	NULL
MF	NULL
.	NULL

,	NULL
Hunter	NULL
,	NULL
T	NULL
.	NULL

and	NULL
Verma	NULL
,	NULL
I	NULL
.	NULL

M.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
10	NULL
,	NULL
5473-5485	NULL
.	NULL

Capobianco	NULL
,	NULL
A.J	NULL
.	NULL

and	NULL
Gilmore	NULL
,	NULL
T.D	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Oncogene	NULL
,	NULL
6	NULL
,	NULL
2203-2210	NULL
.	NULL

Capobianco	NULL
,	NULL
A.J	NULL
.	NULL

,	NULL
Chang	NULL
,	NULL
D.	NULL
,	NULL
Mosialos	NULL
,	NULL
G	NULL
.	NULL

and	NULL
Gilmore	NULL
,	NULL
T.D	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
66	NULL
,	NULL
3758-3767	NULL
.	NULL

Cordle	NULL
,	NULL
S.R	NULL
.	NULL

,	NULL
Donald	NULL
,	NULL
R.	NULL
,	NULL
Read	NULL
,	NULL
M.A	NULL
.	NULL

and	NULL
Hawiger	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
268	NULL
,	NULL
11803-11810	NULL
.	NULL

Davis	NULL
,	NULL
N.	NULL
,	NULL
Ghosh	NULL
,	NULL
S.	NULL
,	NULL
Simmons	NULL
,	NULL
D.L	NULL
.	NULL

,	NULL
Tempst	NULL
,	NULL
P.	NULL
,	NULL
Liou	NULL
,	NULL
H.-C.	NULL
,	NULL
Baltimore	NULL
,	NULL
D.	NULL
and	NULL
Bose	NULL
,	NULL
H.R	NULL
.	NULL

,	NULL
Jr	NULL
(	NULL
1991	NULL
)	NULL
Science	NULL
,	NULL
253	NULL
,	NULL
1268-1271	NULL
.	NULL

Fan	NULL
,	NULL
C.-M.	NULL
and	NULL
Maniatis	NULL
,	NULL
T	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Nature	NULL
,	NULL
354	NULL
,	NULL
395-398	NULL
.	NULL

Fujita	NULL
,	NULL
T	NULL
.	NULL

,	NULL
Nolan	NULL
,	NULL
G.P	NULL
.	NULL

,	NULL
Ghosh	NULL
,	NULL
S	NULL
.	NULL

and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1992	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

,	NULL
6	NULL
,	NULL
775-787	NULL
.	NULL

Ghosh	NULL
,	NULL
S	NULL
.	NULL

and	NULL
Baltimore	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Nature	NULL
,	NULL
344	NULL
,	NULL
678-682	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
Gifford	NULL
,	NULL
A.M.	NULL
,	NULL
Riviere	NULL
,	NULL
L.R	NULL
.	NULL

,	NULL
Tempst	NULL
,	NULL
P.	NULL
,	NULL
Nolan	NULL
,	NULL
G.P	NULL
.	NULL

and	NULL
Baltimore	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
,	NULL
62	NULL
,	NULL
1019-1029	NULL
.	NULL

Grilli	NULL
,	NULL
M.	NULL
,	NULL
Chiu	NULL
,	NULL
J.J.-S.	NULL
and	NULL
Lenardo	NULL
,	NULL
M.J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Int	NULL
.	NULL

Rev	NULL
.	NULL

Cytol	NULL
.	NULL

,	NULL
143	NULL
,	NULL
1-62	NULL
.	NULL

Hannink	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Temin	NULL
,	NULL
H.M	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Oncogene	NULL
,	NULL
5	NULL
,	NULL
1843-1850	NULL
.	NULL

Hansen	NULL
,	NULL
S.K	NULL
.	NULL

,	NULL
Nerlov	NULL
,	NULL
C.	NULL
,	NULL
Zabel	NULL
,	NULL
U.	NULL
,	NULL
Verde	NULL
,	NULL
P.	NULL
,	NULL
Johnsen	NULL
,	NULL
M.	NULL
,	NULL
Bacuerle	NULL
,	NULL
P	NULL
.A	NULL
.	NULL

and	NULL
Blasi	NULL
,	NULL
F	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
EMBO	NULL
J.	NULL
,	NULL
11	NULL
,	NULL
205-213	NULL
.	NULL

Haskill	NULL
,	NULL
$	NULL
.	NULL

,	NULL
Beg	NULL
,	NULL
A.A.	NULL
,	NULL
Tompkins	NULL
,	NULL
S.M	NULL
.	NULL

,	NULL
Morris	NULL
,	NULL
J.S	NULL
.	NULL

,	NULL
Yurochko	NULL
,	NULL
A.D.	NULL
,	NULL
Sampson-Johannes	NULL
,	NULL
A.	NULL
,	NULL
Mondal	NULL
,	NULL
K.	NULL
,	NULL
Ralph	NULL
,	NULL
P	NULL
.	NULL

and	NULL
Baldwin	NULL
,	NULL
A.S.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
,	NULL
65	NULL
,	NULL
1281-1289	NULL
.	NULL

Hohmann	NULL
,	NULL
H.-P.	NULL
,	NULL
Remy	NULL
,	NULL
R.	NULL
,	NULL
Poschl	NULL
,	NULL
B	NULL
.	NULL

and	NULL
van	NULL
Loon	NULL
,	NULL
A.P.G.M	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
265	NULL
,	NULL
15183-15188	NULL
.	NULL

Hohmann	NULL
,	NULL
H.-P.	NULL
,	NULL
Remy	NULL
,	NULL
R.	NULL
,	NULL
Scheidereit	NULL
,	NULL
C	NULL
.	NULL

and	NULL
Van	NULL
Loon	NULL
,	NULL
A.P.G.M	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
11	NULL
,	NULL
259-266	NULL
.	NULL

Inoue	NULL
,	NULL
J.-I	NULL
.	NULL

,	NULL
Kerr	NULL
,	NULL
L.D	NULL
.	NULL

,	NULL
Ransone	NULL
,	NULL
L.J	NULL
.	NULL

,	NULL
Bengal	NULL
,	NULL
E.	NULL
,	NULL
Hunter	NULL
,	NULL
T.	NULL
and	NULL
Verma	NULL
,	NULL
L	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
88	NULL
,	NULL
3715-3719	NULL
.	NULL

Kert	NULL
,	NULL
L.D	NULL
.	NULL

,	NULL
Inoue	NULL
,	NULL
J	NULL
.	NULL

-I.	NULL
,	NULL
Davis	NULL
,	NULL
N.	NULL
,	NULL
Link	NULL
,	NULL
E.	NULL
,	NULL
Baeuerle	NULL
,	NULL
P.A	NULL
.	NULL

,	NULL
Bose	NULL
,	NULL
H.R	NULL
.	NULL

,	NULL
Jr	NULL
and	NULL
Verma	NULL
,	NULL
LM	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

,	NULL
5	NULL
,	NULL
1464-1476	NULL
.	NULL

Kieran	NULL
,	NULL
M	NULL
.	NULL

et	NULL
al	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
,	NULL
62	NULL
,	NULL
1007-1018	NULL
.	NULL

Kochel	NULL
,	NULL
T.	NULL
,	NULL
Mushinski	NULL
,	NULL
J.F	NULL
.	NULL

and	NULL
Rice	NULL
,	NULL
N.R	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Oncogene	NULL
,	NULL
6	NULL
,	NULL
615-626	NULL
.	NULL

Libermann	NULL
,	NULL
T.A	NULL
.	NULL

and	NULL
Baltimore	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
10	NULL
,	NULL
2327-2334	NULL
.	NULL

Liu	NULL
,	NULL
F.-T.	NULL
,	NULL
Zinnecker	NULL
,	NULL
M.	NULL
,	NULL
Hamaoka	NULL
,	NULL
T	NULL
.	NULL

and	NULL
Katz	NULL
,	NULL
D.H	NULL
.	NULL

(	NULL
1979	NULL
)	NULL
Biochemistry	NULL
,	NULL
18	NULL
,	NULL
690-697	NULL
.	NULL

Mercurio	NULL
,	NULL
F.	NULL
,	NULL
DiDonato	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Rosette	NULL
,	NULL
C.	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

,	NULL
7	NULL
,	NULL
705-718	NULL
.	NULL

Meyer	NULL
,	NULL
R	NULL
.	NULL

et	NULL
al	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
88	NULL
,	NULL
966-970	NULL
.	NULL

Neri	NULL
,	NULL
A.	NULL
,	NULL
Chang	NULL
,	NULL
C.-C.	NULL
,	NULL
Lombardi	NULL
,	NULL
L.	NULL
,	NULL
Salina	NULL
,	NULL
M.	NULL
,	NULL
Corradini	NULL
,	NULL
P.	NULL
,	NULL
Maiolo	NULL
,	NULL
A.T	NULL
.	NULL

,	NULL
Chaganti	NULL
,	NULL
R.S.K	NULL
.	NULL

and	NULL
Dalla-Favera	NULL
,	NULL
R	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Cell	NULL
,	NULL
67	NULL
,	NULL
1075-1087	NULL
.	NULL

Nolan	NULL
,	NULL
G.P	NULL
.	NULL

,	NULL
Ghosh	NULL
,	NULL
S.	NULL
,	NULL
Liou	NULL
,	NULL
H.-C.	NULL
,	NULL
Tempst	NULL
,	NULL
P	NULL
.	NULL

and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
,	NULL
64	NULL
,	NULL
961-969	NULL
.	NULL

Perkins	NULL
,	NULL
N.D.	NULL
,	NULL
Schmid	NULL
,	NULL
R.M	NULL
.	NULL

,	NULL
Duckett	NULL
,	NULL
C.S	NULL
.	NULL

,	NULL
Leung	NULL
,	NULL
K.	NULL
,	NULL
Rice	NULL
,	NULL
N.R	NULL
.	NULL

and	NULL
Nabel	NULL
,	NULL
G.J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
89	NULL
,	NULL
1529-1533	NULL
.	NULL

Rice	NULL
,	NULL
N.R	NULL
.	NULL

,	NULL
MacKichan	NULL
,	NULL
M.L	NULL
.	NULL

and	NULL
Israél	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Cell	NULL
,	NULL
71	NULL
,	NULL
243-253	NULL
.	NULL

Ruben	NULL
,	NULL
S.M	NULL
.	NULL

,	NULL
Dillon	NULL
,	NULL
P.J	NULL
.	NULL

,	NULL
Schreck	NULL
,	NULL
R.	NULL
,	NULL
Henkel	NULL
,	NULL
T.	NULL
,	NULL
Chen	NULL
,	NULL
C.-H.	NULL
,	NULL
Maher	NULL
,	NULL
M.	NULL
,	NULL
Bacuerle	NULL
,	NULL
P.A	NULL
.	NULL

and	NULL
Rosen	NULL
,	NULL
C.A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Science	NULL
,	NULL
251	NULL
,	NULL
1490-1493	NULL
.	NULL

Ruben	NULL
,	NULL
$	NULL
.M	NULL
.	NULL

,	NULL
Klement	NULL
,	NULL
J.F	NULL
.	NULL

,	NULL
Coleman	NULL
,	NULL
T.A	NULL
.	NULL

,	NULL
Maher	NULL
,	NULL
M.	NULL
,	NULL
Chen	NULL
,	NULL
C.-H.	NULL
and	NULL
Rosen	NULL
,	NULL
C.A	NULL
.	NULL

(	NULL
1992a	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

,	NULL
6	NULL
,	NULL
745-760	NULL
.	NULL

Ruben	NULL
,	NULL
S.M	NULL
.	NULL

,	NULL
Narayanan	NULL
,	NULL
R.	NULL
,	NULL
Klement	NULL
,	NULL
J.F	NULL
.	NULL

,	NULL
Chen	NULL
,	NULL
C.-H.	NULL
and	NULL
Rosen	NULL
,	NULL
C.A	NULL
.	NULL

(	NULL
1992b	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
12	NULL
,	NULL
444-454	NULL
.	NULL

Ryseck	NULL
,	NULL
R.-P.	NULL
,	NULL
Bull	NULL
,	NULL
P.	NULL
,	NULL
Takamiya	NULL
,	NULL
M.	NULL
,	NULL
Bours	NULL
,	NULL
V.	NULL
,	NULL
Siebenlist	NULL
,	NULL
U.	NULL
,	NULL
Dobrzanski	NULL
,	NULL
P	NULL
.	NULL

and	NULL
Bravo	NULL
,	NULL
R	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
12	NULL
,	NULL
674-684	NULL
.	NULL

Schmid	NULL
,	NULL
R.M	NULL
.	NULL

,	NULL
Perkins	NULL
,	NULL
N.D.	NULL
,	NULL
Duckett	NULL
,	NULL
C.S	NULL
.	NULL

,	NULL
Andrews	NULL
,	NULL
P.C	NULL
.	NULL

and	NULL
Nabel	NULL
,	NULL
G.J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Nature	NULL
,	NULL
352	NULL
,	NULL
733-736	NULL
.	NULL

Schmitz	NULL
,	NULL
M.L	NULL
.	NULL

and	NULL
Baeuerle	NULL
,	NULL
P.A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
EMBO	NULL
J.	NULL
,	NULL
10	NULL
,	NULL
3805-3817	NULL
.	NULL

Scott	NULL
,	NULL
M.L	NULL
.	NULL

,	NULL
Fujita	NULL
,	NULL
T.	NULL
,	NULL
Liou	NULL
,	NULL
H.-C.	NULL
,	NULL
Nolan	NULL
,	NULL
G.P	NULL
.	NULL

and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

,	NULL
7	NULL
,	NULL
1266-1276	NULL
.	NULL

Sen	NULL
,	NULL
R	NULL
.	NULL

and	NULL
Baltimore	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1986a	NULL
)	NULL
Cell	NULL
,	NULL
46	NULL
,	NULL
705-716	NULL
.	NULL

Sen	NULL
,	NULL
R	NULL
.	NULL

and	NULL
Baltimore	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1986b	NULL
)	NULL
Cell	NULL
,	NULL
47	NULL
,	NULL
921-928	NULL
.	NULL

Shirakawa	NULL
,	NULL
F	NULL
.	NULL

and	NULL
Mizel	NULL
,	NULL
S	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
9	NULL
,	NULL
2424-2430	NULL
.	NULL

Sun	NULL
,	NULL
$	NULL
.-C.	NULL
,	NULL
Ganchi	NULL
,	NULL
P	NULL
.	NULL

A.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
and	NULL
Greene	NULL
,	NULL
W.C.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
,	NULL
259	NULL
,	NULL
1912-1915	NULL
.	NULL

Ten	NULL
,	NULL
R.M	NULL
.	NULL

,	NULL
Paya	NULL
,	NULL
C.V.	NULL
,	NULL
Isracl	NULL
,	NULL
N.	NULL
,	NULL
LeBail	NULL
,	NULL
O.	NULL
,	NULL
Mattei	NULL
,	NULL
M.-G.	NULL
,	NULL
Virelizier	NULL
,	NULL
J.-L.	NULL
,	NULL
Kourilsky	NULL
,	NULL
P	NULL
.	NULL

and	NULL
Israél	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
EMBO	NULL
J.	NULL
,	NULL
11	NULL
,	NULL
195-203	NULL
.	NULL

Tewari	NULL
,	NULL
M.	NULL
,	NULL
Dobrzanski	NULL
,	NULL
P.	NULL
,	NULL
Mohn	NULL
,	NULL
K.L	NULL
.	NULL

,	NULL
Cressman	NULL
,	NULL
D.E	NULL
.	NULL

,	NULL
Hsu	NULL
,	NULL
J.-C.	NULL
,	NULL
Bravo	NULL
,	NULL
R	NULL
.	NULL

and	NULL
Taub	NULL
,	NULL
R	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
12	NULL
,	NULL
2898-2908	NULL
.	NULL

Urban	NULL
,	NULL
.M.A	NULL
.	NULL

,	NULL
Schreck	NULL
,	NULL
R	NULL
.	NULL

and	NULL
Bacuerle	NULL
,	NULL
P.A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
EMBO	NULL
J.	NULL
,	NULL
10	NULL
,	NULL
1817-1825	NULL
.	NULL

Instability	NULL
of	NULL
IxBa	NULL
complexes	NULL
WalL	NULL
,	NULL
R.	NULL
,	NULL
Briskin	NULL
,	NULL
M.	NULL
,	NULL
Carter	NULL
,	NULL
C.	NULL
,	NULL
Govan	NULL
,	NULL
H.	NULL
,	NULL
Taylor	NULL
,	NULL
A	NULL
.	NULL

and	NULL
Kincade	NULL
,	NULL
P	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
83	NULL
,	NULL
295-298	NULL
.	NULL

Wulczyn	NULL
,	NULL
F.G.	NULL
,	NULL
Naumann	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Scheidereit	NULL
,	NULL
C	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Nature	NULL
,	NULL
358	NULL
,	NULL
597-599	NULL
.	NULL

Zabel	NULL
,	NULL
U	NULL
.	NULL

and	NULL
Bacuerle	NULL
,	NULL
P.A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
,	NULL
61	NULL
,	NULL
255-265	NULL
.	NULL

Zabel	NULL
,	NULL
U.	NULL
,	NULL
Henkel	NULL
,	NULL
T.	NULL
,	NULL
Silva	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Baeuerle	NULL
,	NULL
P	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
EMBO	NULL
J.	NULL
,	NULL
12	NULL
,	NULL
201-211	NULL
.	NULL

Received	NULL
on	NULL
June	NULL
11	NULL
,	NULL
1993	NULL
;	NULL
revised	NULL
on	NULL
August	NULL
23	NULL
,	NULL
1993	NULL
4695	NULL

